| 1 |
Hung IF, Cheng VC, Wu AK, Tang BS, Chan KH, Chu CM, Wong MM, Hui WT, Poon LL, Tse DM, Chan KS, Woo PC, Lau SK, Peiris JS, Yuen KY. Viral loads in clinical specimens and SARS manifestations. Emerg Infect Dis. 2004;10:1550-1557. [PMID: 15498155 DOI: 10.3201/eid1009.040058] [Cited by in Crossref: 174] [Cited by in F6Publishing: 153] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 2 |
Chan-Yeung M, Xu RH. SARS: epidemiology. Respirology. 2003;8 Suppl:S9-14. [PMID: 15018127 DOI: 10.1046/j.1440-1843.2003.00518.x] [Cited by in Crossref: 320] [Cited by in F6Publishing: 261] [Article Influence: 17.8] [Reference Citation Analysis]
|
| 3 |
Cai Y, Liu J, Yang H, Chen T, Yu Q, Chen J, Huang D, Chen Z, Shang QL, Ma C, Chen X, Xiao E. Correlation between early features and prognosis of symptomatic COVID-19 discharged patients in Hunan, China. Sci Rep 2021;11:4304. [PMID: 33619362 DOI: 10.1038/s41598-021-83654-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Zeng Q, Li YZ, Dong SY, Chen ZT, Gao XY, Zhang H, Huang G, Xu Y. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension. Front Immunol 2020;11:596684. [PMID: 33362779 DOI: 10.3389/fimmu.2020.596684] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 5 |
Saxena A. Drug targets for COVID-19 therapeutics: Ongoing global efforts. J Biosci 2020;45:87. [PMID: 32661214 [PMID: 32661214 DOI: 10.1007/s12038-020-00067-w] [Cited by in Crossref: 35] [Cited by in F6Publishing: 12] [Article Influence: 17.5] [Reference Citation Analysis]
|
| 6 |
Saha BK, Chong WH, Austin A, Kathuria R, Datar P, Shkolnik B, Beegle S, Chopra A. Pleural abnormalities in COVID-19: a narrative review. J Thorac Dis 2021;13:4484-99. [PMID: 34422375 DOI: 10.21037/jtd-21-542] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 7 |
Chan WM, Liu DT, Chan PK, Chong KK, Yuen KS, Chiu TY, Tam BS, Ng JS, Lam DS. Precautions in ophthalmic practice in a hospital with a major acute SARS outbreak: an experience from Hong Kong. Eye (Lond) 2006;20:283-9. [PMID: 15877099 DOI: 10.1038/sj.eye.6701885] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 8 |
McRitchie D, Farooq W, Fisher HN. Use of drotrecogin alfa (activated) in a severe acute respiratory syndrome patient with severe sepsis. Can J Infect Dis Med Microbiol 2008;19:258-9. [PMID: 19412386 DOI: 10.1155/2008/501759] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 9 |
Khan H, Winstone H, Jimenez-Guardeño JM, Graham C, Doores KJ, Goujon C, Matthews DA, Davidson AD, Rihn SJ, Palmarini M, Neil SJD, Malim MH. TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction. PLoS Pathog 2021;17:e1009820. [PMID: 34807954 DOI: 10.1371/journal.ppat.1009820] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Verbeek PR, McClelland IW, Silverman AC, Burgess RJ. Loss of paramedic availability in an urban emergency medical services system during a severe acute respiratory syndrome outbreak. Acad Emerg Med 2004;11:973-8. [PMID: 15347550 DOI: 10.1197/j.aem.2004.03.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 11 |
Bakharev SD, Baulo EV, Bykova SV, Dbar SR, Parfenov AI. COVID-19 and the small intestine. Terapevticheskii arkhiv 2021;93:343-7. [DOI: 10.26442/00403660.2021.03.200662] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 12 |
Tseng CT, Sbrana E, Iwata-Yoshikawa N, Newman PC, Garron T, Atmar RL, Peters CJ, Couch RB. Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus. PLoS One. 2012;7:e35421. [PMID: 22536382 DOI: 10.1371/journal.pone.0035421] [Cited by in Crossref: 267] [Cited by in F6Publishing: 283] [Article Influence: 26.7] [Reference Citation Analysis]
|
| 13 |
Lai LWC, Chau KW, Ho DCW, Lin VYY. Impact of Political Incidents, Financial Crises, and Severe Acute Respiratory Syndrome on Hong Kong Property Buyers. Environ Plann B Plann Des 2006;33:413-33. [DOI: 10.1068/b31125a] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 14 |
Zhang SF, Tuo JL, Huang XB, Zhu X, Zhang DM, Zhou K, Yuan L, Luo HJ, Zheng BJ, Yuen KY, Li MF, Cao KY, Xu L. Epidemiology characteristics of human coronaviruses in patients with respiratory infection symptoms and phylogenetic analysis of HCoV-OC43 during 2010-2015 in Guangzhou. PLoS One 2018;13:e0191789. [PMID: 29377913 DOI: 10.1371/journal.pone.0191789] [Cited by in Crossref: 56] [Cited by in F6Publishing: 64] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 15 |
Moreau GB, Burgess SL, Sturek JM, Donlan AN, Petri WA, Mann BJ. Evaluation of K18-hACE2 Mice as a Model of SARS-CoV-2 Infection. Am J Trop Med Hyg 2020;103:1215-9. [PMID: 32723427 DOI: 10.4269/ajtmh.20-0762] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 19.0] [Reference Citation Analysis]
|
| 16 |
Panambur B, Kakkilaya SB. Palmar Erythema as the Sole Manifestation of COVID-19. Cureus 2020;12:e11291. [PMID: 33274164 DOI: 10.7759/cureus.11291] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 17 |
Wu Q, Zhou L, Sun X, Yan Z, Hu C, Wu J, Xu L, Li X, Liu H, Yin P, Li K, Zhao J, Li Y, Wang X, Li Y, Zhang Q, Xu G, Chen H. Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection. Sci Rep 2017;7:9110. [PMID: 28831119 DOI: 10.1038/s41598-017-09536-z] [Cited by in Crossref: 177] [Cited by in F6Publishing: 178] [Article Influence: 35.4] [Reference Citation Analysis]
|
| 18 |
Kaye M. SARS-associated coronavirus replication in cell lines. Emerg Infect Dis 2006;12:128-33. [PMID: 16494729 DOI: 10.3201/eid1201.050496] [Cited by in Crossref: 70] [Cited by in F6Publishing: 69] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 19 |
Rainer T, Cameron P, Smit D. Should Differential White Cell Counts be Reported as Percentages or Absolute Counts in Patients with Severe Acute Respiratory Syndrome? Hong Kong Journal of Emergency Medicine 2004;11:12-5. [DOI: 10.1177/102490790401100103] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 20 |
Hwang DM, Chamberlain DW, Poutanen SM, Low DE, Asa SL, Butany J. Pulmonary pathology of severe acute respiratory syndrome in Toronto. Mod Pathol. 2005;18:1-10. [PMID: 15272286 DOI: 10.1038/modpathol.3800247] [Cited by in Crossref: 209] [Cited by in F6Publishing: 186] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 21 |
Khalil BA, Elemam NM, Maghazachi AA. Chemokines and chemokine receptors during COVID-19 infection. Comput Struct Biotechnol J 2021;19:976-88. [PMID: 33558827 DOI: 10.1016/j.csbj.2021.01.034] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 22 |
Cheng A, Zhang W, Xie Y, Jiang W, Arnold E, Sarafianos SG, Ding J. Expression, purification, and characterization of SARS coronavirus RNA polymerase. Virology 2005;335:165-76. [PMID: 15840516 DOI: 10.1016/j.virol.2005.02.017] [Cited by in Crossref: 78] [Cited by in F6Publishing: 74] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 23 |
Poon LL, Chan KH, Peiris JS. Crouching tiger, hidden dragon: the laboratory diagnosis of severe acute respiratory syndrome. Clin Infect Dis 2004;38:297-9. [PMID: 14699466 DOI: 10.1086/380848] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 24 |
He ML, Zheng BJ, Chen Y, Wong KL, Huang JD, Lin MC, Peng Y, Yuen KY, Sung JJ, Kung HF. Kinetics and synergistic effects of siRNAs targeting structural and replicase genes of SARS-associated coronavirus. FEBS Lett 2006;580:2414-20. [PMID: 16638566 DOI: 10.1016/j.febslet.2006.03.066] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 25 |
Lu L, Manopo I, Leung BP, Chng HH, Ling AE, Chee LL, Ooi EE, Chan SW, Kwang J. Immunological characterization of the spike protein of the severe acute respiratory syndrome coronavirus. J Clin Microbiol 2004;42:1570-6. [PMID: 15071006 DOI: 10.1128/JCM.42.4.1570-1576.2004] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 26 |
Lee YS, Chen CH, Chao A, Chen ES, Wei ML, Chen LK, Yang KD, Lin MC, Wang YH, Liu JW, Eng HL, Chiang PC, Wu TS, Tsao KC, Huang CG, Tien YJ, Wang TH, Wang HS, Lee YS. Molecular signature of clinical severity in recovering patients with severe acute respiratory syndrome coronavirus (SARS-CoV). BMC Genomics 2005;6:132. [PMID: 16174304 DOI: 10.1186/1471-2164-6-132] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 27 |
Johnston LB, Conly JM. Severe acute respiratory syndrome: What have we learned two years later? Can J Infect Dis Med Microbiol 2004;15:309-12. [PMID: 18159508 DOI: 10.1155/2004/964258] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 28 |
Yuan K, Yi L, Chen J, Qu X, Qing T, Rao X, Jiang P, Hu J, Xiong Z, Nie Y, Shi X, Wang W, Ling C, Yin X, Fan K, Lai L, Ding M, Deng H. Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein. Biochem Biophys Res Commun 2004;319:746-52. [PMID: 15184046 DOI: 10.1016/j.bbrc.2004.05.046] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 29 |
Mohapatra RK, Pintilie L, Kandi V, Sarangi AK, Das D, Sahu R, Perekhoda L. The recent challenges of highly contagious COVID-19, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and immunotherapy. Chem Biol Drug Des 2020;96:1187-208. [PMID: 32654267 DOI: 10.1111/cbdd.13761] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 12.5] [Reference Citation Analysis]
|
| 30 |
Yang ZY, Huang Y, Ganesh L, Leung K, Kong WP, Schwartz O, Subbarao K, Nabel GJ. pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. J Virol 2004;78:5642-50. [PMID: 15140961 DOI: 10.1128/JVI.78.11.5642-5650.2004] [Cited by in Crossref: 338] [Cited by in F6Publishing: 263] [Article Influence: 18.8] [Reference Citation Analysis]
|
| 31 |
Smales FC, Samaranyake LP. Maintaining dental education and specialist dental care during an outbreak of a new coronavirus infection. Part 1: a deadly viral epidemic begins. Br Dent J 2003;195:557-61. [PMID: 14631425 DOI: 10.1038/sj.bdj.4810723] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 32 |
Majumdar S, Murphy PM. Chemokine Regulation During Epidemic Coronavirus Infection. Front Pharmacol 2020;11:600369. [PMID: 33613280 DOI: 10.3389/fphar.2020.600369] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 33 |
Sloots TP, Whiley DM, Lambert SB, Nissen MD. Emerging respiratory agents: new viruses for old diseases? J Clin Virol 2008;42:233-43. [PMID: 18406664 DOI: 10.1016/j.jcv.2008.03.002] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 34 |
Augustine R, S A, Nayeem A, Salam SA, Augustine P, Dan P, Maureira P, Mraiche F, Gentile C, Hansbro PM, McClements L, Hasan A. Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin-angiotensin-aldosterone system (RAAS) dysregulation. Chem Biol Interact 2021;351:109738. [PMID: 34740598 DOI: 10.1016/j.cbi.2021.109738] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 35 |
Yount B, Curtis KM, Fritz EA, Hensley LE, Jahrling PB, Prentice E, Denison MR, Geisbert TW, Baric RS. Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus. Proc Natl Acad Sci U S A 2003;100:12995-3000. [PMID: 14569023 DOI: 10.1073/pnas.1735582100] [Cited by in Crossref: 264] [Cited by in F6Publishing: 255] [Article Influence: 13.9] [Reference Citation Analysis]
|
| 36 |
Tong S, Lingappa JR, Chen Q, Shu B, LaMonte AC, Cook BT, Birge C, Chern SW, Liu X, Galloway R, Mai le Q, Ng WF, Yang JY, Butany J, Comer JA, Monroe SS, Beard SR, Ksiazek TG, Erdman D, Rota PA, Pallansch MA, Anderson LJ. Direct sequencing of SARS-coronavirus S and N genes from clinical specimens shows limited variation. J Infect Dis 2004;190:1127-31. [PMID: 15319863 DOI: 10.1086/422849] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 37 |
Conly JM, Johnston BL. SARS : A Tale of Two Epidemics. Can J Infect Dis 2003;14:147-9. [PMID: 18159447 DOI: 10.1155/2003/912170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 38 |
Li G, Zhao Z, Chen L, Zhou Y. Mild severe acute respiratory syndrome. Emerg Infect Dis 2003;9:1182-3. [PMID: 14531381 DOI: 10.3201/eid0909.030461] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 39 |
Ye J, Zhang B, Xu J, Chang Q, McNutt MA, Korteweg C, Gong E, Gu J. Molecular pathology in the lungs of severe acute respiratory syndrome patients. Am J Pathol 2007;170:538-45. [PMID: 17255322 DOI: 10.2353/ajpath.2007.060469] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 40 |
Ströher U, DiCaro A, Li Y, Strong JE, Aoki F, Plummer F, Jones SM, Feldmann H. Severe acute respiratory syndrome-related coronavirus is inhibited by interferon- alpha. J Infect Dis 2004;189:1164-7. [PMID: 15031783 DOI: 10.1086/382597] [Cited by in Crossref: 140] [Cited by in F6Publishing: 132] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 41 |
Yuan X, Li J, Shan Y, Yang Z, Zhao Z, Chen B, Yao Z, Dong B, Wang S, Chen J, Cong Y. Subcellular localization and membrane association of SARS-CoV 3a protein. Virus Res 2005;109:191-202. [PMID: 15763150 DOI: 10.1016/j.virusres.2005.01.001] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 42 |
Kelly MG, Sharkey RA, Moles KW, Daly JG. Severe community-acquired pneumococcal pneumonia (CAP) - a potentially fatal illness. J Med Microbiol 2004;53:83-4. [PMID: 14663110 DOI: 10.1099/jmm.0.05338-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 43 |
Sweileh WM. Global research trends of World Health Organization's top eight emerging pathogens. Global Health 2017;13:9. [PMID: 28179007 DOI: 10.1186/s12992-017-0233-9] [Cited by in Crossref: 88] [Cited by in F6Publishing: 76] [Article Influence: 17.6] [Reference Citation Analysis]
|
| 44 |
Al-Tawfiq JA, Memish ZA. Middle East Respiratory Syndrome Coronavirus and Severe Acute Respiratory Syndrome Coronavirus. Semin Respir Crit Care Med. 2020;41:568-578. [PMID: 32305045 DOI: 10.1055/s-0040-1709160] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 45 |
Zhong X, Yang H, Guo ZF, Sin WY, Chen W, Xu J, Fu L, Wu J, Mak CK, Cheng CS, Yang Y, Cao S, Wong TY, Lai ST, Xie Y, Guo Z. B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein. J Virol 2005;79:3401-8. [PMID: 15731234 DOI: 10.1128/JVI.79.6.3401-3408.2005] [Cited by in Crossref: 69] [Cited by in F6Publishing: 52] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 46 |
Wong SY, Lim WW, Que TL, Au DM. Reflection on SARS precautions in a severe intellectual disabilities hospital in Hong Kong. J Intellect Disabil Res 2005;49:379-84. [PMID: 15817055 DOI: 10.1111/j.1365-2788.2005.00687.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 47 |
Tomlinson B, Cockram C. SARS: experience at Prince of Wales Hospital, Hong Kong. Lancet. 2003;361:1486-1487. [PMID: 12737853 DOI: 10.1016/s0140-6736(03)13218-7] [Cited by in Crossref: 100] [Cited by in F6Publishing: 66] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 48 |
Tatsis N, Ertl HC. Adenoviruses as vaccine vectors. Mol Ther 2004;10:616-29. [PMID: 15451446 DOI: 10.1016/j.ymthe.2004.07.013] [Cited by in Crossref: 361] [Cited by in F6Publishing: 348] [Article Influence: 21.2] [Reference Citation Analysis]
|
| 49 |
Tan TT, Tan BH, Kurup A, Oon LL, Heng D, Thoe SY, Bai XL, Chan KP, Ling AE. Atypical SARS and Escherichia coli bacteremia. Emerg Infect Dis 2004;10:349-52. [PMID: 15030711 DOI: 10.3201/eid1002.030501] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 50 |
Chan VS, Chan KY, Chen Y, Poon LL, Cheung AN, Zheng B, Chan KH, Mak W, Ngan HY, Xu X, Screaton G, Tam PK, Austyn JM, Chan LC, Yip SP, Peiris M, Khoo US, Lin CL. Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection. Nat Genet 2006;38:38-46. [PMID: 16369534 DOI: 10.1038/ng1698] [Cited by in Crossref: 99] [Cited by in F6Publishing: 96] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 51 |
Chen L, Liu S, Tian J, Pan H, Liu Y, Hu J, Wang M, Hou X. Disease progression patterns and risk factors associated with mortality in deceased patients with COVID-19 in Hubei Province, China. Immun Inflamm Dis 2020;8:584-94. [PMID: 32857453 DOI: 10.1002/iid3.343] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 52 |
Wong GW, Fok TF. Severe acute respiratory syndrome (SARS) in children. Pediatr Pulmonol Suppl 2004;26:69-71. [PMID: 15029602 DOI: 10.1002/ppul.70056] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 53 |
Ferrarini MG, Lal A, Rebollo R, Gruber AJ, Guarracino A, Gonzalez IM, Floyd T, de Oliveira DS, Shanklin J, Beausoleil E, Pusa T, Pickett BE, Aguiar-Pulido V. Genome-wide bioinformatic analyses predict key host and viral factors in SARS-CoV-2 pathogenesis. Commun Biol 2021;4:590. [PMID: 34002013 DOI: 10.1038/s42003-021-02095-0] [Reference Citation Analysis]
|
| 54 |
Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, Yang P, Sarao R, Wada T, Leong-Poi H, Crackower MA, Fukamizu A, Hui CC, Hein L, Uhlig S, Slutsky AS, Jiang C, Penninger JM. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436:112-116. [PMID: 16001071 DOI: 10.1038/nature03712] [Cited by in Crossref: 1473] [Cited by in F6Publishing: 1350] [Article Influence: 86.6] [Reference Citation Analysis]
|
| 55 |
Wallinga J, Teunis P. Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures. Am J Epidemiol 2004;160:509-16. [PMID: 15353409 DOI: 10.1093/aje/kwh255] [Cited by in Crossref: 786] [Cited by in F6Publishing: 569] [Article Influence: 43.7] [Reference Citation Analysis]
|
| 56 |
Su JR. Emerging viral infections. Clin Lab Med 2004;24:773-95, vii. [PMID: 15325064 DOI: 10.1016/j.cll.2004.05.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 57 |
Chan JF, Li KS, To KK, Cheng VC, Chen H, Yuen KY. Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic? J Infect 2012;65:477-89. [PMID: 23072791 DOI: 10.1016/j.jinf.2012.10.002] [Cited by in Crossref: 111] [Cited by in F6Publishing: 106] [Article Influence: 11.1] [Reference Citation Analysis]
|
| 58 |
Du L, Kou Z, Ma C, Tao X, Wang L, Zhao G, Chen Y, Yu F, Tseng CT, Zhou Y, Jiang S. A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines. PLoS One 2013;8:e81587. [PMID: 24324708 DOI: 10.1371/journal.pone.0081587] [Cited by in Crossref: 117] [Cited by in F6Publishing: 115] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 59 |
Hsueh PR, Huang LM, Chen PJ, Kao CL, Yang PC. Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus. Clin Microbiol Infect 2004;10:1062-6. [PMID: 15606632 DOI: 10.1111/j.1469-0691.2004.01009.x] [Cited by in Crossref: 160] [Cited by in F6Publishing: 143] [Article Influence: 9.4] [Reference Citation Analysis]
|
| 60 |
Mukherjee P, Shah F, Desai P, Avery M. Inhibitors of SARS-3CLpro: virtual screening, biological evaluation, and molecular dynamics simulation studies. J Chem Inf Model 2011;51:1376-92. [PMID: 21604711 DOI: 10.1021/ci1004916] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 61 |
Mahmud-Al-Rafat A, Majumder A, Taufiqur Rahman KM, Mahedi Hasan AM, Didarul Islam KM, Taylor-Robinson AW, Billah MM. Decoding the enigma of antiviral crisis: Does one target molecule regulate all? Cytokine 2019;115:13-23. [PMID: 30616034 DOI: 10.1016/j.cyto.2018.12.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 62 |
Chen L, Li J, Luo C, Liu H, Xu W, Chen G, Liew OW, Zhu W, Puah CM, Shen X, Jiang H. Binding interaction of quercetin-3-beta-galactoside and its synthetic derivatives with SARS-CoV 3CL(pro): structure-activity relationship studies reveal salient pharmacophore features. Bioorg Med Chem 2006;14:8295-306. [PMID: 17046271 DOI: 10.1016/j.bmc.2006.09.014] [Cited by in F6Publishing: 120] [Reference Citation Analysis]
|
| 63 |
Wong RS, Hui DS. Index patient and SARS outbreak in Hong Kong. Emerg Infect Dis 2004;10:339-41. [PMID: 15030708 DOI: 10.3201/eid1002.030645] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 64 |
Woo PC, Lau SK, Tsoi HW, Chan KH, Wong BH, Che XY, Tam VK, Tam SC, Cheng VC, Hung IF, Wong SS, Zheng BJ, Guan Y, Yuen KY. Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia. Lancet 2004;363:841-5. [PMID: 15031027 DOI: 10.1016/S0140-6736(04)15729-2] [Cited by in Crossref: 103] [Cited by in F6Publishing: 90] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 65 |
Lam CM, Wong SF, Leung TN, Chow KM, Yu WC, Wong TY, Lai ST, Ho LC. A case-controlled study comparing clinical course and outcomes of pregnant and non-pregnant women with severe acute respiratory syndrome. BJOG 2004;111:771-4. [PMID: 15270922 DOI: 10.1111/j.1471-0528.2004.00199.x] [Cited by in Crossref: 158] [Cited by in F6Publishing: 142] [Article Influence: 8.8] [Reference Citation Analysis]
|
| 66 |
Meltzer MI. Multiple contact dates and SARS incubation periods. Emerg Infect Dis 2004;10:207-9. [PMID: 15030684 DOI: 10.3201/eid1002.030426] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 67 |
Chang HL, Chen KT, Lai SK, Kuo HW, Su IJ, Lin RS, Sung FC. Hematological and biochemical factors predicting SARS fatality in Taiwan. J Formos Med Assoc. 2006;105:439-450. [PMID: 16801031 DOI: 10.1016/s0929-6646(09)60183-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 68 |
Wei WI, Ho WK. Severe acute respiratory syndrome: what have we learned. Adv Surg 2005;39:343-54. [PMID: 16250560 DOI: 10.1016/j.yasu.2005.04.001] [Reference Citation Analysis]
|
| 69 |
Cesario TC. Viruses associated with pneumonia in adults. Clin Infect Dis 2012;55:107-13. [PMID: 22423119 DOI: 10.1093/cid/cis297] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 70 |
Jernigan JA, Low DE, Hefland RF. Combining clinical and epidemiologic features for early recognition of SARS. Emerg Infect Dis 2004;10:327-33. [PMID: 15030706 DOI: 10.3201/eid1002.030741] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 71 |
Burkle FM Jr. Population-based triage management in response to surge-capacity requirements during a large-scale bioevent disaster. Acad Emerg Med 2006;13:1118-29. [PMID: 17015415 DOI: 10.1197/j.aem.2006.06.040] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 72 |
Wang J, Tang Y, Ma Y, Zhou Q, Li W, Baskota M, Yang Y, Wang X, Li Q, Luo X, Fukuoka T, Ahn HS, Lee MS, Luo Z, Liu E, Chen Y; COVID-19 Evidence and Recommendations Working Group. Efficacy and safety of antibiotic agents in children with COVID-19: a rapid review. Ann Transl Med 2020;8:619. [PMID: 32566556 DOI: 10.21037/atm-20-3300] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 73 |
Wu CY, Jan JT, Ma SH, Kuo CJ, Juan HF, Cheng YS, Hsu HH, Huang HC, Wu D, Brik A, Liang FS, Liu RS, Fang JM, Chen ST, Liang PH, Wong CH. Small molecules targeting severe acute respiratory syndrome human coronavirus. Proc Natl Acad Sci U S A 2004;101:10012-7. [PMID: 15226499 DOI: 10.1073/pnas.0403596101] [Cited by in Crossref: 279] [Cited by in F6Publishing: 268] [Article Influence: 15.5] [Reference Citation Analysis]
|
| 74 |
Inci F, Tokel O, Wang S, Gurkan UA, Tasoglu S, Kuritzkes DR, Demirci U. Nanoplasmonic quantitative detection of intact viruses from unprocessed whole blood. ACS Nano 2013;7:4733-45. [PMID: 23688050 DOI: 10.1021/nn3036232] [Cited by in Crossref: 126] [Cited by in F6Publishing: 97] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 75 |
Hui DS. Epidemic and Emerging Coronaviruses (Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome). Clin Chest Med 2017;38:71-86. [PMID: 28159163 DOI: 10.1016/j.ccm.2016.11.007] [Cited by in Crossref: 75] [Cited by in F6Publishing: 62] [Article Influence: 12.5] [Reference Citation Analysis]
|
| 76 |
Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, Alvarado-Arnez LE, Bonilla-Aldana DK, Franco-Paredes C, Henao-Martinez AF, Paniz-Mondolfi A, Lagos-Grisales GJ, Ramírez-Vallejo E, Suárez JA, Zambrano LI, Villamil-Gómez WE, Balbin-Ramon GJ, Rabaan AA, Harapan H, Dhama K, Nishiura H, Kataoka H, Ahmad T, Sah R; Latin American Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19). Electronic address: https://www.lancovid.org. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis 2020;34:101623. [PMID: 32179124 DOI: 10.1016/j.tmaid.2020.101623] [Cited by in Crossref: 970] [Cited by in F6Publishing: 796] [Article Influence: 485.0] [Reference Citation Analysis]
|
| 77 |
Wong SF, Chow KM, Leung TN, Ng WF, Ng TK, Shek CC, Ng PC, Lam PW, Ho LC, To WW, Lai ST, Yan WW, Tan PY. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol 2004;191:292-7. [PMID: 15295381 DOI: 10.1016/j.ajog.2003.11.019] [Cited by in Crossref: 572] [Cited by in F6Publishing: 458] [Article Influence: 31.8] [Reference Citation Analysis]
|
| 78 |
Peng H, Yang LT, Wang LY, Li J, Huang J, Lu ZQ, Koup RA, Bailer RT, Wu CY. Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients. Virology 2006;351:466-75. [PMID: 16690096 DOI: 10.1016/j.virol.2006.03.036] [Cited by in Crossref: 103] [Cited by in F6Publishing: 94] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 79 |
Ni L, Zhu J, Zhang J, Yan M, Gao GF, Tien P. Design of recombinant protein-based SARS-CoV entry inhibitors targeting the heptad-repeat regions of the spike protein S2 domain. Biochem Biophys Res Commun 2005;330:39-45. [PMID: 15781229 DOI: 10.1016/j.bbrc.2005.02.117] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 80 |
Shinoda S; Collaborative Research Center for Infectious Diseases in India, Okayama University Tsushima-naka, Okayama, Okayama 700-8530, Japan. COVID-19 and Spanish Flu, the Representative Pandemics of the 21st and 20th Centuries. JDR 2022;17:65-72. [DOI: 10.20965/jdr.2022.p0065] [Reference Citation Analysis]
|
| 81 |
Poon LL, Chan KH, Wong OK, Cheung TK, Ng I, Zheng B, Seto WH, Yuen KY, Guan Y, Peiris JS. Detection of SARS coronavirus in patients with severe acute respiratory syndrome by conventional and real-time quantitative reverse transcription-PCR assays. Clin Chem 2004;50:67-72. [PMID: 14709637 DOI: 10.1373/clinchem.2003.023663] [Cited by in Crossref: 96] [Cited by in F6Publishing: 85] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 82 |
Apisarnthanarak A, Warren DK, Fraser VJ. Issues relevant to the adoption and modification of hospital infection-control recommendations for avian influenza (H5N1 infection) in developing countries. Clin Infect Dis 2007;45:1338-42. [PMID: 17968831 DOI: 10.1086/522538] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 83 |
Yu F, Le MQ, Inoue S, Thai HT, Hasebe F, Del Carmen Parquet M, Morita K. Evaluation of inapparent nosocomial severe acute respiratory syndrome coronavirus infection in Vietnam by use of highly specific recombinant truncated nucleocapsid protein-based enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol 2005;12:848-54. [PMID: 16002634 DOI: 10.1128/CDLI.12.7.848-854.2005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 84 |
Lu HY, Xu XY, Lei Y, Wu YF, Chen BW, Xiao F, Xie GQ, Han DM. Clinical features of probable severe acute respiratory syndrome in Beijing. World J Gastroenterol 2005; 11(19): 2971-2974 [PMID: 15902739 DOI: 10.3748/wjg.v11.i19.2971] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 85 |
Chow SC, Ho CY, Tam TT, Wu C, Cheung T, Chan PK, Ng MH, Hui PK, Ng HK, Au DM, Lo AW. Specific epitopes of the structural and hypothetical proteins elicit variable humoral responses in SARS patients. J Clin Pathol 2006;59:468-76. [PMID: 16461566 DOI: 10.1136/jcp.2005.029868] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 86 |
Martínez-Téllez E, Orús Dotú C, Trujillo-Reyes JC, Guarino M, Cladellas Gutiérrez E, Planas Cánovas G, Ramon Cervelló J, Carvi Mallo A, Venegas Pizarro MDP, León Vintró X, Belda-Sanchis J. Tracheotomy in patients COVID-19: A necessary high risk procedure. Two center experience. Arch Bronconeumol 2020;56:673-4. [PMID: 34024988 DOI: 10.1016/j.arbr.2020.05.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 87 |
Ramakrishna S, Padhi S, Priyakumar UD. Modeling the structure of SARS 3a transmembrane protein using a minimum unfavorable contact approach. J Chem Sci (Bangalore) 2015;127:2159-69. [PMID: 32218650 DOI: 10.1007/s12039-015-0982-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 88 |
Ip WK, Chan KH, Law HK, Tso GH, Kong EK, Wong WH, To YF, Yung RW, Chow EY, Au KL, Chan EY, Lim W, Jensenius JC, Turner MW, Peiris JS, Lau YL. Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. J Infect Dis 2005;191:1697-704. [PMID: 15838797 DOI: 10.1086/429631] [Cited by in Crossref: 165] [Cited by in F6Publishing: 157] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 89 |
Yi L, Li Z, Yuan K, Qu X, Chen J, Wang G, Zhang H, Luo H, Zhu L, Jiang P, Chen L, Shen Y, Luo M, Zuo G, Hu J, Duan D, Nie Y, Shi X, Wang W, Han Y, Li T, Liu Y, Ding M, Deng H, Xu X. Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells. J Virol 2004;78:11334-9. [PMID: 15452254 DOI: 10.1128/JVI.78.20.11334-11339.2004] [Cited by in Crossref: 181] [Cited by in F6Publishing: 127] [Article Influence: 10.1] [Reference Citation Analysis]
|
| 90 |
Schlottau K, Rissmann M, Graaf A, Schön J, Sehl J, Wylezich C, Höper D, Mettenleiter TC, Balkema-Buschmann A, Harder T, Grund C, Hoffmann D, Breithaupt A, Beer M. SARS-CoV-2 in fruit bats, ferrets, pigs, and chickens: an experimental transmission study. Lancet Microbe 2020;1:e218-25. [PMID: 32838346 DOI: 10.1016/S2666-5247(20)30089-6] [Cited by in Crossref: 180] [Cited by in F6Publishing: 124] [Article Influence: 90.0] [Reference Citation Analysis]
|
| 91 |
Zhai J, Briese T, Dai E, Wang X, pang X, Du Z, Liu H, Wang J, Wang H, Guo Z, Chen Z, Jiang L, Zhou D, Han Y, Jabado O, Palacios G, Lipkin WI, Tang R. Real-time polymerase chain reaction for detecting SARS coronavirus, Beijing, 2003. Emerg Infect Dis 2004;10:300-3. [PMID: 15030701 DOI: 10.3201/eid1002.030799] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 92 |
Chen YC, Huang LM, Chan CC, Su CP, Chang SC, Chang YY, Chen ML, Hung CC, Chen WJ, Lin FY, Lee YT; SARS Research Group of National Taiwan University College of Medicine and National Taiwan University Hospital. SARS in hospital emergency room. Emerg Infect Dis 2004;10:782-8. [PMID: 15200809 DOI: 10.3201/eid1005.030579] [Cited by in Crossref: 105] [Cited by in F6Publishing: 93] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 93 |
Peiris JS, Guan Y, Yuen KY. Severe acute respiratory syndrome. Nat Med 2004;10:S88-97. [PMID: 15577937 DOI: 10.1038/nm1143] [Cited by in Crossref: 636] [Cited by in F6Publishing: 564] [Article Influence: 37.4] [Reference Citation Analysis]
|
| 94 |
Oba Y. The use of corticosteroids in SARS. N Engl J Med 2003;348:2034-5; author reply 2034-5. [PMID: 12748321 DOI: 10.1056/NEJM200305153482017] [Cited by in Crossref: 41] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 95 |
Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, Fan Y, Zheng C. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20:425-434. [PMID: 32105637 DOI: 10.1016/s1473-3099(20)30086-4] [Cited by in Crossref: 1675] [Cited by in F6Publishing: 1103] [Article Influence: 837.5] [Reference Citation Analysis]
|
| 96 |
Leung TF, Wong GW, Hon KL, Fok TF. Severe acute respiratory syndrome (SARS) in children: epidemiology, presentation and management. Paediatr Respir Rev 2003;4:334-9. [PMID: 14629957 DOI: 10.1016/s1526-0542(03)00088-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 97 |
Poon LLM, Chan KH, Nicholls JM, Zheng BJ, Yuen KY, Guan Y, Peiris JSM. Characterization of a novel coronavirus responsible for severe acute respiratory syndrome. Int Congr Ser 2004;1263:805-8. [PMID: 32288144 DOI: 10.1016/j.ics.2004.02.105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 98 |
Wong E, Ho KK. The effect of severe acute respiratory syndrome (SARS) on emergency airway management. Resuscitation 2006;70:26-30. [PMID: 16762480 DOI: 10.1016/j.resuscitation.2005.11.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 99 |
Hui DS, Sung JJ. Severe acute respiratory syndrome. Chest 2003;124:12-5. [PMID: 12853495 DOI: 10.1378/chest.124.1.12] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 100 |
Guihot A, Bricaire F, Li T, Bossi P. [Severe acute respiratory syndrome: a singular epidemic of viral pneumonia]. Presse Med 2004;33:344-51. [PMID: 15041887 DOI: 10.1016/s0755-4982(04)98581-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 101 |
Li SY, Chen C, Zhang HQ, Guo HY, Wang H, Wang L, Zhang X, Hua SN, Yu J, Xiao PG, Li RS, Tan X. Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res 2005;67:18-23. [PMID: 15885816 DOI: 10.1016/j.antiviral.2005.02.007] [Cited by in Crossref: 259] [Cited by in F6Publishing: 228] [Article Influence: 15.2] [Reference Citation Analysis]
|
| 102 |
Wong CKH, Wong JYH, Tang EHM, Au CH, Wai AKC. Clinical presentations, laboratory and radiological findings, and treatments for 11,028 COVID-19 patients: a systematic review and meta-analysis. Sci Rep 2020;10:19765. [PMID: 33188232 DOI: 10.1038/s41598-020-74988-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 103 |
Liu W, Tang F, Fontanet A, Zhan L, Wang TB, Zhang PH, Luan YH, Cao CY, Zhao QM, Wu XM, Xin ZT, Zuo SQ, Baril L, Vabret A, Shao YM, Yang H, Cao WC. Molecular epidemiology of SARS-associated coronavirus, Beijing. Emerg Infect Dis 2005;11:1420-4. [PMID: 16229772 DOI: 10.3201/eid1109.040773] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 104 |
Chui L, Drebot M, Andonov A, Petrich A, Glushek M, Mahony J. Comparison of 9 different PCR primers for the rapid detection of severe acute respiratory syndrome coronavirus using 2 RNA extraction methods. Diagn Microbiol Infect Dis 2005;53:47-55. [PMID: 15994050 DOI: 10.1016/j.diagmicrobio.2005.03.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 105 |
Chen HI, Kao SJ, Wang D, Lee RP, Su CF. Acute respiratory distress syndrome. J Biomed Sci 2003;10:588-92. [PMID: 14576460 DOI: 10.1159/000073523] [Cited by in Crossref: 36] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 106 |
Chan JW, Ng CK, Chan YH, Mok TY, Lee S, Chu SY, Law WL, Lee MP, Li PC. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax 2003;58:686-9. [PMID: 12885985 DOI: 10.1136/thorax.58.8.686] [Cited by in Crossref: 216] [Cited by in F6Publishing: 203] [Article Influence: 11.4] [Reference Citation Analysis]
|
| 107 |
Li RW, Leung KW, Sun FC, Samaranayake LP. Severe Acute Respiratory Syndrome (SARS) and the GDP. Part I : Epidemiology, virology, pathology and general health issues. Br Dent J 2004;197:77-80. [PMID: 15272339 DOI: 10.1038/sj.bdj.4811469] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 108 |
Stip E, Rizvi TA, Mustafa F, Javaid S, Aburuz S, Ahmed NN, Abdel Aziz K, Arnone D, Subbarayan A, Al Mugaddam F, Khan G. The Large Action of Chlorpromazine: Translational and Transdisciplinary Considerations in the Face of COVID-19. Front Pharmacol 2020;11:577678. [PMID: 33390948 DOI: 10.3389/fphar.2020.577678] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 109 |
Chen YM, Liang SY, Shih YP, Chen CY, Lee YM, Chang L, Jung SY, Ho MS, Liang KY, Chen HY, Chan YJ, Chu DC. Epidemiological and genetic correlates of severe acute respiratory syndrome coronavirus infection in the hospital with the highest nosocomial infection rate in Taiwan in 2003. J Clin Microbiol. 2006;44:359-365. [PMID: 16455884 DOI: 10.1128/jcm.44.2.359-365.2006] [Cited by in Crossref: 62] [Cited by in F6Publishing: 39] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 110 |
Shih MC, Peck K, Chan WL, Chu YP, Chen JC, Tsai CH, Chang JG. SARS-CoV infection was from at least two origins in the Taiwan area. Intervirology 2005;48:124-32. [PMID: 15812185 DOI: 10.1159/000081739] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 111 |
Nichols WG, Peck Campbell AJ, Boeckh M. Respiratory viruses other than influenza virus: impact and therapeutic advances. Clin Microbiol Rev 2008;21:274-90, table of contents. [PMID: 18400797 DOI: 10.1128/CMR.00045-07] [Cited by in Crossref: 93] [Cited by in F6Publishing: 51] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 112 |
Prabhu S, Vijayakumar S, Praseetha P. Cyanobacterial metabolites as novel drug candidates in corona viral therapies: A review. Chronic Diseases and Translational Medicine. [DOI: 10.1002/cdt3.11] [Reference Citation Analysis]
|
| 113 |
Hui DS, Chan MC, Wu AK, Ng PC. Severe acute respiratory syndrome (SARS): epidemiology and clinical features. Postgrad Med J 2004;80:373-81. [PMID: 15254300 DOI: 10.1136/pgmj.2004.020263] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 114 |
Galvani AP, Lei X, Jewell NP. Severe acute respiratory syndrome: temporal stability and geographic variation in case-fatality rates and doubling times. Emerg Infect Dis 2003;9:991-4. [PMID: 12967499 DOI: 10.3201/eid0908.030334] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 115 |
Wang H, Mao Y, Ju L, Zhang J, Liu Z, Zhou X, Li Q, Wang Y, Kim S, Zhang L. Detection and monitoring of SARS coronavirus in the plasma and peripheral blood lymphocytes of patients with severe acute respiratory syndrome. Clin Chem 2004;50:1237-40. [PMID: 15229153 DOI: 10.1373/clinchem.2004.031237] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 116 |
Chen YC, Chang SC, Tsai KS, Lin FY. Certainties and uncertainties facing emerging respiratory infectious diseases: lessons from SARS. J Formos Med Assoc 2008;107:432-42. [PMID: 18583213 DOI: 10.1016/S0929-6646(08)60150-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 117 |
Nicholls JM, Poon LL, Lee KC, Ng WF, Lai ST, Leung CY, Chu CM, Hui PK, Mak KL, Lim W, Yan KW, Chan KH, Tsang NC, Guan Y, Yuen KY, Peiris JS. Lung pathology of fatal severe acute respiratory syndrome. Lancet. 2003;361:1773-1778. [PMID: 12781536 DOI: 10.1016/s0140-6736(03)13413-7] [Cited by in Crossref: 687] [Cited by in F6Publishing: 522] [Article Influence: 36.2] [Reference Citation Analysis]
|
| 118 |
Feng D, de Vlas SJ, Fang LQ, Han XN, Zhao WJ, Sheng S, Yang H, Jia ZW, Richardus JH, Cao WC. The SARS epidemic in mainland China: bringing together all epidemiological data. Trop Med Int Health 2009;14 Suppl 1:4-13. [PMID: 19508441 DOI: 10.1111/j.1365-3156.2008.02145.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 119 |
Tong HH, Shekunov BY, Chan JP, Mok CK, Hung HC, Chow AH. An improved thermoanalytical approach to quantifying trace levels of polymorphic impurity in drug powders. Int J Pharm 2005;295:191-9. [PMID: 15848004 DOI: 10.1016/j.ijpharm.2005.02.024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 120 |
Santerre M, Arjona SP, Allen CN, Shcherbik N, Sawaya BE. Why do SARS-CoV-2 NSPs rush to the ER? J Neurol 2021;268:2013-22. [PMID: 32870373 DOI: 10.1007/s00415-020-10197-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 121 |
van Elden LJ, van Loon AM, van Alphen F, Hendriksen KA, Hoepelman AI, van Kraaij MG, Oosterheert JJ, Schipper P, Schuurman R, Nijhuis M. Frequent detection of human coronaviruses in clinical specimens from patients with respiratory tract infection by use of a novel real-time reverse-transcriptase polymerase chain reaction. J Infect Dis 2004;189:652-7. [PMID: 14767819 DOI: 10.1086/381207] [Cited by in Crossref: 139] [Cited by in F6Publishing: 129] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 122 |
Zhang CH, Lu JH, Wang YF, Zheng HY, Xiong S, Zhang MY, Liu XJ, Li JX, Wan ZY, Yan XG, Qi SY, Cui Z, Zhang B. Immune responses in Balb/c mice induced by a candidate SARS-CoV inactivated vaccine prepared from F69 strain. Vaccine 2005;23:3196-201. [PMID: 15837220 DOI: 10.1016/j.vaccine.2004.11.073] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 123 |
Koteswara Rao V. Point of Care Diagnostic Devices for Rapid Detection of Novel Coronavirus (SARS-nCoV19) Pandemic: A Review. Front Nanotechnol 2021;2:593619. [DOI: 10.3389/fnano.2020.593619] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 124 |
Manohar P, Loh B, Nachimuthu R, Hua X, Welburn SC, Leptihn S. Secondary Bacterial Infections in Patients With Viral Pneumonia. Front Med (Lausanne) 2020;7:420. [PMID: 32850912 DOI: 10.3389/fmed.2020.00420] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 125 |
Wang XW, Li JS, Guo TK, Zhen B, Kong QX, Yi B, Li Z, Song N, Jin M, Wu XM, Xiao WJ, Zhu XM, Gu CQ, Yin J, Wei W, Yao W, Liu C, Li JF, Ou GR, Wang MN, Fang TY, Wang GJ, Qiu YH, Wu HH, Chao FH, Li JW. Excretion and detection of SARS coronavirus and its nucleic acid from digestive system. World J Gastroenterol 2005; 11(28): 4390-4395 [PMID: 16038039 DOI: 10.3748/wjg.v11.i28.4390] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 126 |
Hui DS. Severe acute respiratory syndrome (SARS): lessons learnt in Hong Kong. J Thorac Dis 2013;5 Suppl 2:S122-6. [PMID: 23977432 DOI: 10.3978/j.issn.2072-1439.2013.06.18] [Cited by in F6Publishing: 23] [Reference Citation Analysis]
|
| 127 |
Aguas R, Ferguson NM. Feature selection methods for identifying genetic determinants of host species in RNA viruses. PLoS Comput Biol 2013;9:e1003254. [PMID: 24130470 DOI: 10.1371/journal.pcbi.1003254] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 128 |
Farquharson C, Baguley K. Responding to the Severe Acute Respiratory Syndrome (SARS) Outbreak: Lessons Learned in a Toronto Emergency Department. J Emerg Nurs 2020;46:742-7. [PMID: 33162020 DOI: 10.1016/j.jen.2020.04.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 129 |
Kim HJ. Novel respiratory infectious diseases in Korea. Yeungnam Univ J Med 2020;37:286-95. [PMID: 33045803 DOI: 10.12701/yujm.2020.00633] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 130 |
Maves RC, Jamros CM, Smith AG. Intensive Care Unit Preparedness During Pandemics and Other Biological Threats. Crit Care Clin 2019;35:609-18. [PMID: 31445608 DOI: 10.1016/j.ccc.2019.06.001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 131 |
Wu D, Yang LC, Wu SS. Crisis management of SARS in a hospital. J Safety Res 2004;35:345-9. [PMID: 15288568 DOI: 10.1016/j.jsr.2003.11.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 132 |
Bossi P, Guihot A, Ansart S, Bricaire F. [Severe acute respiratory syndrome: update]. Rev Med Interne 2003;24:672-80. [PMID: 14550520 DOI: 10.1016/s0248-8663(03)00262-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 133 |
Papineau A, Berhane Y, Wylie TN, Wylie KM, Sharpe S, Lung O. Genome Organization of Canada Goose Coronavirus, A Novel Species Identified in a Mass Die-off of Canada Geese. Sci Rep 2019;9:5954. [PMID: 30976080 DOI: 10.1038/s41598-019-42355-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 134 |
Hui DS, Chan PK. Severe acute respiratory syndrome and coronavirus. Infect Dis Clin North Am 2010;24:619-38. [PMID: 20674795 DOI: 10.1016/j.idc.2010.04.009] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 135 |
García-Montero C, Fraile-Martínez O, Bravo C, Torres-Carranza D, Sanchez-Trujillo L, Gómez-Lahoz AM, Guijarro LG, García-Honduvilla N, Asúnsolo A, Bujan J, Monserrat J, Serrano E, Álvarez-Mon M, De León-Luis JA, Álvarez-Mon MA, Ortega MA. An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times. Vaccines (Basel) 2021;9:433. [PMID: 33925526 DOI: 10.3390/vaccines9050433] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 136 |
Zhao M, Wang M, Zhang J, Ye J, Xu Y, Wang Z, Ye D, Liu J, Wan J. Advances in the relationship between coronavirus infection and cardiovascular diseases. Biomed Pharmacother 2020;127:110230. [PMID: 32428835 DOI: 10.1016/j.biopha.2020.110230] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
|
| 137 |
Lee K, Kim DK, Mo J. Clinical Reviews of COVID-19 for Otorhinolaryngologists. J Rhinol 2021;28:1-13. [DOI: 10.18787/jr.2020.00321] [Reference Citation Analysis]
|
| 138 |
Ewig S. [SARS. A lesson in infection epidemiology and a masterpiece of modern infection control]. Pathologe 2003;24:335-7. [PMID: 12961021 DOI: 10.1007/s00292-003-0637-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 139 |
Chen Z, Lv Y, Xu H, Deng L. Herbal Medicine, Gut Microbiota, and COVID-19. Front Pharmacol 2021;12:646560. [PMID: 34305582 DOI: 10.3389/fphar.2021.646560] [Reference Citation Analysis]
|
| 140 |
Sihoe AD, Wong RH, Lee AT, Lau LS, Leung NY, Law KI, Yim AP. Severe acute respiratory syndrome complicated by spontaneous pneumothorax. Chest 2004;125:2345-51. [PMID: 15189961 DOI: 10.1378/chest.125.6.2345] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 141 |
Lin CW, Lin KH, Hsieh TH, Shiu SY, Li JY. Severe acute respiratory syndrome coronavirus 3C-like protease-induced apoptosis. FEMS Immunol Med Microbiol 2006;46:375-80. [PMID: 16553810 DOI: 10.1111/j.1574-695X.2006.00045.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 50] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 142 |
Anderson RM, Fraser C, Ghani AC, Donnelly CA, Riley S, Ferguson NM, Leung GM, Lam TH, Hedley AJ. Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic. Philos Trans R Soc Lond B Biol Sci. 2004;359:1091-1105. [PMID: 15306395 DOI: 10.1098/rstb.2004.1490] [Cited by in Crossref: 278] [Cited by in F6Publishing: 234] [Article Influence: 15.4] [Reference Citation Analysis]
|
| 143 |
Kuba K, Imai Y, Rao S, Jiang C, Penninger JM. Lessons from SARS: control of acute lung failure by the SARS receptor ACE2. J Mol Med (Berl) 2006;84:814-20. [PMID: 16988814 DOI: 10.1007/s00109-006-0094-9] [Cited by in Crossref: 77] [Cited by in F6Publishing: 72] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 144 |
Kang JS, Jhun BW, Yoon H, Lim SM, Ko E, Park JH, Hwang SY, Lee SU, Lee TR, Cha WC, Shin TG, Sim MS, Jo IJ. The Utility of Preliminary Patient Evaluation in a Febrile Respiratory Infectious Disease Unit outside the Emergency Department. J Korean Med Sci 2017;32:1534-41. [PMID: 28776351 DOI: 10.3346/jkms.2017.32.9.1534] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 145 |
Zheng Z, Yao Z, Wu K, Zheng J. The diagnosis of pandemic coronavirus pneumonia: A review of radiology examination and laboratory test. J Clin Virol 2020;128:104396. [PMID: 32438256 DOI: 10.1016/j.jcv.2020.104396] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 146 |
Zhao GP. SARS molecular epidemiology: a Chinese fairy tale of controlling an emerging zoonotic disease in the genomics era. Philos Trans R Soc Lond B Biol Sci 2007;362:1063-81. [PMID: 17327210 DOI: 10.1098/rstb.2007.2034] [Cited by in Crossref: 50] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 147 |
Demmler GJ, Ligon BL. Severe acute respiratory syndrome (SARS): a review of the history, epidemiology, prevention, and concerns for the future. Semin Pediatr Infect Dis 2003;14:240-4. [PMID: 12913837 DOI: 10.1016/s1045-1870(03)00056-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 148 |
Yuan X, Wu J, Shan Y, Yao Z, Dong B, Chen B, Zhao Z, Wang S, Chen J, Cong Y. SARS coronavirus 7a protein blocks cell cycle progression at G0/G1 phase via the cyclin D3/pRb pathway. Virology 2006;346:74-85. [PMID: 16303160 DOI: 10.1016/j.virol.2005.10.015] [Cited by in Crossref: 86] [Cited by in F6Publishing: 78] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 149 |
Tian D, Sun Y, Zhou J, Ye Q. The global epidemic of SARS-CoV-2 variants and their mutational immune escape. J Med Virol 2021. [PMID: 34609003 DOI: 10.1002/jmv.27376] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 150 |
Jones BM, Ma ES, Peiris JS, Wong PC, Ho JC, Lam B, Lai KN, Tsang KW. Prolonged disturbances of in vitro cytokine production in patients with severe acute respiratory syndrome (SARS) treated with ribavirin and steroids. Clin Exp Immunol. 2004;135:467-473. [PMID: 15008980 DOI: 10.1111/j.1365-2249.2003.02391.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 151 |
Al-Tawfiq JA, Zumla A, Memish ZA. Travel implications of emerging coronaviruses: SARS and MERS-CoV. Travel Med Infect Dis 2014;12:422-8. [PMID: 25047726 DOI: 10.1016/j.tmaid.2014.06.007] [Cited by in Crossref: 95] [Cited by in F6Publishing: 67] [Article Influence: 11.9] [Reference Citation Analysis]
|
| 152 |
Schwab N, Nienhold R, Henkel M, Baschong A, Graber A, Frank A, Mensah N, Koike J, Hernach C, Sachs M, Daun T, Zsikla V, Willi N, Junt T, Mertz KD. COVID-19 Autopsies Reveal Underreporting of SARS-CoV-2 Infection and Scarcity of Co-infections. Front Med 2022;9:868954. [DOI: 10.3389/fmed.2022.868954] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 153 |
Lu H, Zhao Y, Zhang J, Wang Y, Li W, Zhu X, Sun S, Xu J, Ling L, Cai L, Bu D, Chen R. Date of origin of the SARS coronavirus strains. BMC Infect Dis 2004;4:3. [PMID: 15028113 DOI: 10.1186/1471-2334-4-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 154 |
Blanquer Olivas J. [On severe acute respiratory syndrome (SARS): epidemics in the context of globalization]. Arch Bronconeumol 2003;39:243-5. [PMID: 12797937 DOI: 10.1016/s0300-2896(03)75373-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 155 |
Li J, Zheng Y, Zhao L, Yue Z, Pan F, Chen Y, Yu B, Chen Y, Zhao G, Zhou Y, Gao Z. Investigation of the impact of SARS-CoV infection on the immunologic status and lung function after 15 years. BMC Infect Dis 2021;21:1183. [PMID: 34819019 DOI: 10.1186/s12879-021-06881-3] [Reference Citation Analysis]
|
| 156 |
Miller K, McGrath ME, Hu Z, Ariannejad S, Weston S, Frieman M, Jackson WT. Coronavirus interactions with the cellular autophagy machinery. Autophagy 2020;16:2131-9. [PMID: 32964796 DOI: 10.1080/15548627.2020.1817280] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 157 |
Mo H, Zeng G, Ren X, Li H, Ke C, Tan Y, Cai C, Lai K, Chen R, Chan-Yeung M, Zhong N. Longitudinal profile of antibodies against SARS-coronavirus in SARS patients and their clinical significance. Respirology 2006;11:49-53. [PMID: 16423201 DOI: 10.1111/j.1440-1843.2006.00783.x] [Cited by in Crossref: 126] [Cited by in F6Publishing: 107] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 158 |
Risku M, Lappalainen S, Räsänen S, Vesikari T. Detection of human coronaviruses in children with acute gastroenteritis. J Clin Virol 2010;48:27-30. [PMID: 20233673 DOI: 10.1016/j.jcv.2010.02.013] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 159 |
Li L, Wo J, Shao J, Zhu H, Wu N, Li M, Yao H, Hu M, Dennin RH. SARS-coronavirus replicates in mononuclear cells of peripheral blood (PBMCs) from SARS patients. J Clin Virol 2003;28:239-44. [PMID: 14522061 DOI: 10.1016/s1386-6532(03)00195-1] [Cited by in Crossref: 65] [Cited by in F6Publishing: 55] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 160 |
Yam WC, Chan KH, Chow KH, Poon LL, Lam HY, Yuen KY, Seto WH, Peiris JS. Clinical evaluation of real-time PCR assays for rapid diagnosis of SARS coronavirus during outbreak and post-epidemic periods. J Clin Virol 2005;33:19-24. [PMID: 15797361 DOI: 10.1016/j.jcv.2004.09.029] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 161 |
Câmara DAD, Porcacchia AS, Lizier NF, De-sá-júnior PL. A COVID-19 Overview and Potential Applications of Cell Therapy. Biologics 2021;1:177-88. [DOI: 10.3390/biologics1020011] [Reference Citation Analysis]
|
| 162 |
Sutton TC, Subbarao K. Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus. Virology 2015;479-480:247-58. [PMID: 25791336 DOI: 10.1016/j.virol.2015.02.030] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 8.1] [Reference Citation Analysis]
|
| 163 |
Lu HY, Xu XY, Lei Y, Wu YF, Chen BW, Xiao F, Xie GQ, Han DM. Clinical characteristics and staging of SARS: A report of 801 cases in Beijing. Shijie Huaren Xiaohua Zazhi 2004; 12(5): 1144-1148 [DOI: 10.11569/wcjd.v12.i5.1144] [Reference Citation Analysis]
|
| 164 |
Guan Y, Peiris JS, Zheng B, Poon LL, Chan KH, Zeng FY, Chan CW, Chan MN, Chen JD, Chow KY, Hon CC, Hui KH, Li J, Li VY, Wang Y, Leung SW, Yuen KY, Leung FC. Molecular epidemiology of the novel coronavirus that causes severe acute respiratory syndrome. Lancet 2004;363:99-104. [PMID: 14726162 DOI: 10.1016/s0140-6736(03)15259-2] [Cited by in Crossref: 90] [Cited by in F6Publishing: 68] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 165 |
Feng Z, Yang Y, Xu D, Zhang P, McCauley MM, Glasser JW. Timely identification of optimal control strategies for emerging infectious diseases. J Theor Biol 2009;259:165-71. [PMID: 19289133 DOI: 10.1016/j.jtbi.2009.03.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 166 |
Wang WK, Chen SY, Liu IJ, Chen YC, Chen HL, Yang CF, Chen PJ, Yeh SH, Kao CL, Huang LM, Hsueh PR, Wang JT, Sheng WH, Fang CT, Hung CC, Hsieh SM, Su CP, Chiang WC, Yang JY, Lin JH, Hsieh SC, Hu HP, Chiang YP, Wang JT, Yang PC, Chang SC; SARS Research Group of the National Taiwan University/National Taiwan University Hospital. Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis. Emerg Infect Dis 2004;10:1213-9. [PMID: 15324540 DOI: 10.3201/eid1007.031113] [Cited by in Crossref: 132] [Cited by in F6Publishing: 116] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 167 |
Maggiore U, Abramowicz D, Crespo M, Mariat C, Mjoen G, Peruzzi L, Sever MS, Oniscu GC, Hilbrands L, Watschinger B. How should I manage immunosuppression in a kidney transplant patient with COVID-19? Nephrol Dial Transplant. 2020;35:899-904. [PMID: 32441741 DOI: 10.1093/ndt/gfaa130] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 22.5] [Reference Citation Analysis]
|
| 168 |
Samaranayake LP, Peiris M. Severe acute respiratory syndrome and dentistry: a retrospective view. J Am Dent Assoc 2004;135:1292-302. [PMID: 15493394 DOI: 10.14219/jada.archive.2004.0405] [Cited by in Crossref: 72] [Cited by in F6Publishing: 55] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 169 |
Chen HI, Kao SJ, Wang D, Lee RP, Su CF. Acute respiratory distress syndrome. J Biomed Sci. 2003;10:588-592. [PMID: 14576460 DOI: 10.1159/000073523] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 170 |
Chau TN, Lee KC, Yao H, Tsang TY, Chow TC, Yeung YC, Choi KW, Tso YK, Lau T, Lai ST, Lai CL. SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases. Hepatology 2004;39:302-10. [PMID: 14767982 DOI: 10.1002/hep.20111] [Reference Citation Analysis]
|
| 171 |
Li H, Wang CY, Wang JX, Tang NL, Xie L, Gong YY, Yang Z, Xu LY, Kong QP, Zhang YP. The neck-region polymorphism of DC-SIGNR in peri-centenarian from Han Chinese population. BMC Med Genet 2009;10:134. [PMID: 20003397 DOI: 10.1186/1471-2350-10-134] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 172 |
Chau TN, Lee KC, Yao H, Tsang TY, Chow TC, Yeung YC, Choi KW, Tso YK, Lau T, Lai ST, Lai CL. SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases. Hepatology 2004;39:302-10. [PMID: 14767982 DOI: 10.1002/hep.20111] [Cited by in Crossref: 261] [Cited by in F6Publishing: 232] [Article Influence: 14.5] [Reference Citation Analysis]
|
| 173 |
Yip TC, Lui GC, Wong VW, Chow VC, Ho TH, Li TC, Tse YK, Hui DS, Chan HL, Wong GL. Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19. Gut 2021;70:733-42. [PMID: 32641471 DOI: 10.1136/gutjnl-2020-321726] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 54.0] [Reference Citation Analysis]
|
| 174 |
Lu HY, Xu XY, Lei Y, Wu YF, Chen BW, Xiao F, Xie GQ, Han DM. Characteristics of 1 062 patients with SARS in early stage in Beijing. Shijie Huaren Xiaohua Zazhi 2004; 12(5): 1149-1154 [DOI: 10.11569/wcjd.v12.i5.1149] [Reference Citation Analysis]
|
| 175 |
Timen A, van Doornum GJ, Schutten M, Conyn-van Spaendonck MA, van der Meer JW, Osterhaus AD, van Steenbergen JE. Public health implications of using various case definitions in The Netherlands during the worldwide SARS outbreak. Clin Microbiol Infect 2006;12:1214-20. [PMID: 17121628 DOI: 10.1111/j.1469-0691.2006.01552.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 176 |
Zumla A, Hui DS, Perlman S. Middle East respiratory syndrome. Lancet. 2015;386:995-1007. [PMID: 26049252 DOI: 10.1016/s0140-6736(15)60454-8] [Cited by in Crossref: 598] [Cited by in F6Publishing: 451] [Article Influence: 85.4] [Reference Citation Analysis]
|
| 177 |
Kopel J, Perisetti A, Gajendran M, Boregowda U, Goyal H. Clinical Insights into the Gastrointestinal Manifestations of COVID-19. Dig Dis Sci. 2020;65:1932-1939. [PMID: 32447742 DOI: 10.1007/s10620-020-06362-8] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 23.5] [Reference Citation Analysis]
|
| 178 |
Roberts A, Paddock C, Vogel L, Butler E, Zaki S, Subbarao K. Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans. J Virol 2005;79:5833-8. [PMID: 15827197 DOI: 10.1128/JVI.79.9.5833-5838.2005] [Cited by in Crossref: 151] [Cited by in F6Publishing: 126] [Article Influence: 8.9] [Reference Citation Analysis]
|
| 179 |
Wong T, Wallington T, McDonald LC, Abbas Z, Christian M, Low DE, Gravel D, Ofner M, Mederski B, Berger L, Hansen L, Harrison C, King A, Yaffe B, Tam T. Late recognition of SARS in nosocomial outbreak, Toronto. Emerg Infect Dis 2005;11:322-5. [PMID: 15752456 DOI: 10.3201/eid1102.040607] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 180 |
Chatterjee P, Nair P, Chersich M, Terefe Y, Chauhan AS, Quesada F, Simpson G. One Health, "Disease X" & the challenge of "Unknown" Unknowns. Indian J Med Res 2021;153:264-71. [PMID: 33906988 DOI: 10.4103/ijmr.IJMR_601_21] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 181 |
Gu SX, Tyagi T, Jain K, Gu VW, Lee SH, Hwa JM, Kwan JM, Krause DS, Lee AI, Halene S, Martin KA, Chun HJ, Hwa J. Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. Nat Rev Cardiol 2021;18:194-209. [PMID: 33214651 DOI: 10.1038/s41569-020-00469-1] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 24.5] [Reference Citation Analysis]
|
| 182 |
Chen CY, Lee CH, Liu CY, Wang JH, Wang LM, Perng RP. Clinical features and outcomes of severe acute respiratory syndrome and predictive factors for acute respiratory distress syndrome. J Chin Med Assoc. 2005;68:4-10. [PMID: 15742856 DOI: 10.1016/s1726-4901(09)70124-8] [Cited by in Crossref: 61] [Cited by in F6Publishing: 49] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 183 |
Wong PN, Mak SK, Lo KY, Tong GM, Wong Y, Watt CL, Wong AK. Clinical presentation and outcome of severe acute respiratory syndrome in dialysis patients. Am J Kidney Dis 2003;42:1075-81. [PMID: 14582052 DOI: 10.1016/j.ajkd.2003.08.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 184 |
Guan CS, Lv ZB, Li JJ, Du YN, Chen H, Cui T, Guo N, Chen BD, Xie RM. CT appearances, patterns of progression, and follow-up of COVID-19: evaluation on thin-section CT. Insights Imaging 2021;12:73. [PMID: 34110540 DOI: 10.1186/s13244-021-01019-0] [Reference Citation Analysis]
|
| 185 |
Yang TC, Li SW, Lai CC, Lu KZ, Chiu MT, Hsieh TH, Wan L, Lin CW. Proteomic analysis for Type I interferon antagonism of Japanese encephalitis virus NS5 protein. Proteomics 2013;13:3442-56. [PMID: 24166946 DOI: 10.1002/pmic.201300001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 186 |
Kumaki Y, Day CW, Wandersee MK, Schow BP, Madsen JS, Grant D, Roth JP, Smee DF, Blatt LM, Barnard DL. Interferon alfacon 1 inhibits SARS-CoV infection in human bronchial epithelial Calu-3 cells. Biochem Biophys Res Commun 2008;371:110-3. [PMID: 18406349 DOI: 10.1016/j.bbrc.2008.04.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 187 |
Lin K, Yee-Tak Fong D, Zhu B, Karlberg J. Environmental factors on the SARS epidemic: air temperature, passage of time and multiplicative effect of hospital infection. Epidemiol Infect 2006;134:223-30. [PMID: 16490124 DOI: 10.1017/S0950268805005054] [Cited by in Crossref: 82] [Cited by in F6Publishing: 50] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 188 |
Woo PC, Lau SK, Wong BH, Tsoi HW, Fung AM, Chan KH, Tam VK, Peiris JS, Yuen KY. Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia. J Clin Microbiol 2004;42:2306-9. [PMID: 15131220 DOI: 10.1128/JCM.42.5.2306-2309.2004] [Cited by in Crossref: 87] [Cited by in F6Publishing: 69] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 189 |
Wilder-Smith A, Earnest A, Paton NI. Use of simple laboratory features to distinguish the early stage of severe acute respiratory syndrome from dengue fever. Clin Infect Dis 2004;39:1818-23. [PMID: 15578405 DOI: 10.1086/426029] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 190 |
Hui RK, Zeng F, Chan CM, Yuen KY, Peiris JS, Leung FC. Reverse transcriptase PCR diagnostic assay for the coronavirus associated with severe acute respiratory syndrome. J Clin Microbiol 2004;42:1994-9. [PMID: 15131160 DOI: 10.1128/JCM.42.5.1994-1999.2004] [Cited by in Crossref: 34] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 191 |
Li T, Qiu Z, Zhang L, Han Y, He W, Liu Z, Ma X, Fan H, Lu W, Xie J, Wang H, Deng G, Wang A. Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome. J Infect Dis 2004;189:648-51. [PMID: 14767818 DOI: 10.1086/381535] [Cited by in Crossref: 160] [Cited by in F6Publishing: 150] [Article Influence: 8.9] [Reference Citation Analysis]
|
| 192 |
File TM Jr, Tsang KW. Severe acute respiratory syndrome: pertinent clinical characteristics and therapy. Treat Respir Med 2005;4:95-106. [PMID: 15813661 DOI: 10.2165/00151829-200504020-00003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 193 |
Wong SS. Reply to comments on "Zika virus transmission: What to concern on its transmission apart from mosquito control" by Viroj Wiwanitkit. J Formos Med Assoc 2016;115:685-6. [PMID: 27174386 DOI: 10.1016/j.jfma.2016.03.007] [Reference Citation Analysis]
|
| 194 |
Oliver AL, Poplin GS, Kahn CA. Emergency Medical Services and 9-1-1 pandemic influenza preparedness: a national assessment. Am J Emerg Med 2012;30:505-9. [PMID: 22306392 DOI: 10.1016/j.ajem.2011.11.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 195 |
Haghani M, Varamini P. Temporal evolution, most influential studies and sleeping beauties of the coronavirus literature. Scientometrics 2021;:1-46. [PMID: 34188334 DOI: 10.1007/s11192-021-04036-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 196 |
Pormohammad A, Ghorbani S, Khatami A, Farzi R, Baradaran B, Turner DL, Turner RJ, Bahr NC, Idrovo JP. Comparison of confirmed COVID-19 with SARS and MERS cases - Clinical characteristics, laboratory findings, radiographic signs and outcomes: A systematic review and meta-analysis. Rev Med Virol. 2020;30:e2112. [PMID: 32502331 DOI: 10.1002/rmv.2112] [Cited by in Crossref: 14] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 197 |
He Z, Dong Q, Zhuang H, Song S, Peng G, Luo G, Dwyer DE. Kinetics of severe acute respiratory syndrome (SARS) coronavirus-specific antibodies in 271 laboratory-confirmed cases of SARS. Clin Diagn Lab Immunol 2004;11:792-4. [PMID: 15242960 DOI: 10.1128/CDLI.11.4.792-794.2004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 198 |
Guan WJ, Zheng XY, Zeng GQ, Zhong NS. Severe acute respiratory syndrome: a vanished evil? J Thorac Dis 2013;5 Suppl 2:S87-9. [PMID: 23977440 DOI: 10.3978/j.issn.2072-1439.2013.02.08] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 199 |
Tan YM, Chow PK, Tan BH, Kurup A, Tan BK, Tan FL, Seldrup J, Heng DM, Ang B, Green J, Wong CY, Soo KC. Management of inpatients exposed to an outbreak of severe acute respiratory syndrome (SARS). J Hosp Infect 2004;58:210-5. [PMID: 15501336 DOI: 10.1016/j.jhin.2004.06.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 200 |
Schmidt M, Brixner V, Ruster B, Hourfar MK, Drosten C, Preiser W, Seifried E, Roth WK. NAT screening of blood donors for severe acute respiratory syndrome coronavirus can potentially prevent transfusion associated transmissions. Transfusion 2004;44:470-5. [PMID: 15043560 DOI: 10.1111/j.1537-2995.2004.03269.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 201 |
Lau AC, So LK, Miu FP, Yung RW, Poon E, Cheung TM, Yam LY. Outcome of coronavirus-associated severe acute respiratory syndrome using a standard treatment protocol. Respirology. 2004;9:173-183. [PMID: 15182266 DOI: 10.1111/j.1440-1843.2004.00588.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 202 |
Galvani AP. Emerging infections: what have we learned from SARS? Emerg Infect Dis 2004;10:1351-2. [PMID: 15338569 DOI: 10.3201/eid1007.040166] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 203 |
Rahim-Taleghani S, Fatemi A, Alavi Moghaddam M, Shojaee M, Abushouk AI, Forouzanfar MM, Baratloo A. Correlation of central venous pressure with venous blood gas analysis parameters; a diagnostic study. Turk J Emerg Med 2017;17:7-11. [PMID: 28345066 DOI: 10.1016/j.tjem.2016.09.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 204 |
Adedeji AO, Singh K, Calcaterra NE, DeDiego ML, Enjuanes L, Weiss S, Sarafianos SG. Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase. Antimicrob Agents Chemother 2012;56:4718-28. [PMID: 22733076 DOI: 10.1128/AAC.00957-12] [Cited by in Crossref: 65] [Cited by in F6Publishing: 43] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 205 |
Minakshi R, Padhan K. The YXXΦ motif within the severe acute respiratory syndrome coronavirus (SARS-CoV) 3a protein is crucial for its intracellular transport. Virol J 2014;11:75. [PMID: 24762043 DOI: 10.1186/1743-422X-11-75] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 206 |
Adedeji AO, Singh K, Kassim A, Coleman CM, Elliott R, Weiss SR, Frieman MB, Sarafianos SG. Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses. Antimicrob Agents Chemother 2014;58:4894-8. [PMID: 24841268 DOI: 10.1128/AAC.02994-14] [Cited by in Crossref: 63] [Cited by in F6Publishing: 46] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 207 |
Holmes KV. SARS coronavirus: a new challenge for prevention and therapy. J Clin Invest 2003;111:1605-9. [PMID: 12782660 DOI: 10.1172/JCI18819] [Cited by in Crossref: 130] [Cited by in F6Publishing: 112] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 208 |
Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, Law KI, Tang BS, Hon TY, Chan CS, Chan KH, Ng JS, Zheng BJ, Ng WL, Lai RW, Guan Y, Yuen KY; HKU/UCH SARS Study Group. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361:1767-1772. [PMID: 12781535 DOI: 10.1016/s0140-6736(03)13412-5] [Cited by in Crossref: 1509] [Cited by in F6Publishing: 1111] [Article Influence: 79.4] [Reference Citation Analysis]
|
| 209 |
Ram S. Coronavirus Research Trends: A 50–Year Bibliometric Assessment. Science & Technology Libraries 2020;39:210-26. [DOI: 10.1080/0194262x.2020.1742270] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 210 |
N/A. N/A. Shijie Huaren Xiaohua Zazhi 2004; 12(1): 233-235 [DOI: 10.11569/wcjd.v12.i1.233] [Reference Citation Analysis]
|
| 211 |
Fujii T, Nakamura T, Iwamoto A. Current concepts in SARS treatment. J Infect Chemother 2004;10:1-7. [PMID: 14991510 DOI: 10.1007/s10156-003-0296-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 212 |
Gebbie EN, Morse SS, Hanson H, McCollum MC, Reddy V, Gebbie KM, Smailes E, Balter S. Training for and maintaining public health surge capacity: a program for disease outbreak investigation by student volunteers. Public Health Rep 2007;122:127-33. [PMID: 17236619 DOI: 10.1177/003335490712200119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 213 |
Park GE, Kang CI, Ko JH, Cho SY, Ha YE, Kim YJ, Peck KR, Song JH, Chung DR. Differential Cell Count and CRP Level in Blood as Predictors for Middle East Respiratory Syndrome Coronavirus Infection in Acute Febrile Patients during Nosocomial Outbreak. J Korean Med Sci 2017;32:151-4. [PMID: 27914145 DOI: 10.3346/jkms.2017.32.1.151] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 214 |
Jamieson DJ, Ellis JE, Jernigan DB, Treadwell TA. Emerging infectious disease outbreaks: old lessons and new challenges for obstetrician-gynecologists. Am J Obstet Gynecol 2006;194:1546-55. [PMID: 16731070 DOI: 10.1016/j.ajog.2005.06.062] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 215 |
Mudgal R, Nehul S, Tomar S. Prospects for mucosal vaccine: shutting the door on SARS-CoV-2. Hum Vaccin Immunother 2020;16:2921-31. [PMID: 32931361 DOI: 10.1080/21645515.2020.1805992] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 216 |
Mushtaq A, El-Azizi M, Khardori N. Category C potential bioterrorism agents and emerging pathogens. Infect Dis Clin North Am 2006;20:423-41, x. [PMID: 16762745 DOI: 10.1016/j.idc.2006.03.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 217 |
Ingallinella P, Bianchi E, Finotto M, Cantoni G, Eckert DM, Supekar VM, Bruckmann C, Carfi A, Pessi A. Structural characterization of the fusion-active complex of severe acute respiratory syndrome (SARS) coronavirus. Proc Natl Acad Sci U S A 2004;101:8709-14. [PMID: 15161975 DOI: 10.1073/pnas.0402753101] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 218 |
Hui DS, Wong PC, Wang C. SARS: clinical features and diagnosis. Respirology 2003;8 Suppl:S20-4. [PMID: 15018129 DOI: 10.1046/j.1440-1843.2003.00520.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 219 |
Emery SL, Erdman DD, Bowen MD, Newton BR, Winchell JM, Meyer RF, Tong S, Cook BT, Holloway BP, McCaustland KA, Rota PA, Bankamp B, Lowe LE, Ksiazek TG, Bellini WJ, Anderson LJ. Real-time reverse transcription-polymerase chain reaction assay for SARS-associated coronavirus. Emerg Infect Dis 2004;10:311-6. [PMID: 15030703 DOI: 10.3201/eid1002.030759] [Cited by in Crossref: 159] [Cited by in F6Publishing: 141] [Article Influence: 8.8] [Reference Citation Analysis]
|
| 220 |
Ali N, Mahmood S. Kidney Injury in COVID-19: an Emerging Concern to the Clinician. SN Compr Clin Med 2020;:1-2. [PMID: 32864574 DOI: 10.1007/s42399-020-00482-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 221 |
de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14:523-534. [PMID: 27344959 DOI: 10.1038/nrmicro.2016.81] [Cited by in Crossref: 1666] [Cited by in F6Publishing: 1484] [Article Influence: 277.7] [Reference Citation Analysis]
|
| 222 |
Gonze A, Hannesse C, Coppens N, Vellemans H, Maury G. SARS-CoV-2-Induced Severe Immune Thrombocytopenic Purpura. J Med Cases 2020;11:166-8. [PMID: 33984082 DOI: 10.14740/jmc3481] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 223 |
Sung JJ, Wu A, Joynt GM, Yuen KY, Lee N, Chan PK, Cockram CS, Ahuja AT, Yu LM, Wong VW, Hui DS. Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak. Thorax. 2004;59:414-420. [PMID: 15115870 DOI: 10.1136/thx.2003.014076] [Cited by in Crossref: 121] [Cited by in F6Publishing: 116] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 224 |
Chiang CH, Shih JF, Su WJ, Perng RP. Eight-month prospective study of 14 patients with hospital-acquired severe acute respiratory syndrome. Mayo Clin Proc 2004;79:1372-9. [PMID: 15544014 DOI: 10.4065/79.11.1372] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 225 |
Gretebeck LM, Subbarao K. Animal models for SARS and MERS coronaviruses. Curr Opin Virol. 2015;13:123-129. [PMID: 26184451 DOI: 10.1016/j.coviro.2015.06.009] [Cited by in Crossref: 108] [Cited by in F6Publishing: 97] [Article Influence: 15.4] [Reference Citation Analysis]
|
| 226 |
Vardhana SA, Wolchok JD. The many faces of the anti-COVID immune response. J Exp Med 2020;217:e20200678. [PMID: 32353870 DOI: 10.1084/jem.20200678] [Cited by in Crossref: 243] [Cited by in F6Publishing: 230] [Article Influence: 121.5] [Reference Citation Analysis]
|
| 227 |
Lau HM, Ng GY, Jones AY, Lee EW, Siu EH, Hui DS. A randomised controlled trial of the effectiveness of an exercise training program in patients recovering from severe acute respiratory syndrome. Aust J Physiother 2005;51:213-9. [PMID: 16321128 DOI: 10.1016/s0004-9514(05)70002-7] [Cited by in Crossref: 53] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 228 |
Zheng WX, Chen LL, Ou HY, Gao F, Zhang CT. Coronavirus phylogeny based on a geometric approach. Mol Phylogenet Evol 2005;36:224-32. [PMID: 15890535 DOI: 10.1016/j.ympev.2005.03.030] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 229 |
Rainer TH, Lee N, Ip M, Galvani AP, Antonio GE, Wong KT, Chan DP, Ng AW, Shing KK, Chau SS, Mak P, Chan PK, Ahuja AT, Hui DS, Sung JJ. Features discriminating SARS from other severe viral respiratory tract infections. Eur J Clin Microbiol Infect Dis 2007;26:121-9. [PMID: 17219094 DOI: 10.1007/s10096-006-0246-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 230 |
Chan KY, Xu MS, Ching JC, So TM, Lai ST, Chu CM, Yam LY, Wong AT, Chung PH, Chan VS, Lin CL, Sham PC, Leung GM, Peiris JS, Khoo US. CD209 (DC-SIGN) -336A>G promoter polymorphism and severe acute respiratory syndrome in Hong Kong Chinese. Hum Immunol 2010;71:702-7. [PMID: 20359516 DOI: 10.1016/j.humimm.2010.03.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 231 |
Wong SS, Yuen KY. The severe acute respiratory syndrome (SARS). J Neurovirol 2005;11:455-68. [PMID: 16287687 DOI: 10.1080/13550280500187724] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 232 |
Poon LL, Chan KH, Wong OK, Yam WC, Yuen KY, Guan Y, Lo YM, Peiris JS. Early diagnosis of SARS coronavirus infection by real time RT-PCR. J Clin Virol 2003;28:233-8. [PMID: 14522060 DOI: 10.1016/j.jcv.2003.08.004] [Cited by in Crossref: 132] [Cited by in F6Publishing: 119] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 233 |
Kuzmin IV, Bozick B, Guagliardo SA, Kunkel R, Shak JR, Tong S, Rupprecht CE. Bats, emerging infectious diseases, and the rabies paradigm revisited. Emerg Health Threats J 2011;4:7159. [PMID: 24149032 DOI: 10.3402/ehtj.v4i0.7159] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 234 |
Leong WF, Tan HC, Ooi EE, Koh DR, Chow VT. Microarray and real-time RT-PCR analyses of differential human gene expression patterns induced by severe acute respiratory syndrome (SARS) coronavirus infection of Vero cells. Microbes Infect 2005;7:248-59. [PMID: 15777647 DOI: 10.1016/j.micinf.2004.11.004] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 235 |
Schaefer EAK, Arvind A, Bloom PP, Chung RT. Interrelationship Between Coronavirus Infection and Liver Disease. Clin Liver Dis (Hoboken). 2020;15:175-180. [PMID: 32489653 DOI: 10.1002/cld.967] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 11.5] [Reference Citation Analysis]
|
| 236 |
Maki DG. SARS: 1918 revisited? The urgent need for global collaboration in public health. Mayo Clin Proc 2003;78:813-6. [PMID: 12839074 DOI: 10.4065/78.7.813] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 237 |
Wong WC, Lee A, Tsang KK, Wong SY. How did general practitioners protect themselves, their family, and staff during the SARS epidemic in Hong Kong? J Epidemiol Community Health 2004;58:180-5. [PMID: 14966227 DOI: 10.1136/jech.2003.015594] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 238 |
Al-Tawfiq JA, Momattin H, Dib J, Memish ZA. Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study. Int J Infect Dis. 2014;20:42-46. [PMID: 24406736 DOI: 10.1016/j.ijid.2013.12.003] [Cited by in Crossref: 200] [Cited by in F6Publishing: 185] [Article Influence: 25.0] [Reference Citation Analysis]
|
| 239 |
Shi X, Gong E, Gao D, Zhang B, Zheng J, Gao Z, Zhong Y, Zou W, Wu B, Fang W, Liao S, Wang S, Xie Z, Lu M, Hou L, Zhong H, Shao H, Li N, Liu C, Pei F, Yang J, Wang Y, Han Z, Shi X, Zhang Q, You J, Zhu X, Gu J. Severe acute respiratory syndrome associated coronavirus is detected in intestinal tissues of fatal cases. Am J Gastroenterol 2005;100:169-76. [PMID: 15654797 DOI: 10.1111/j.1572-0241.2005.40377.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 76] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 240 |
Suhandynata RT, Hoffman MA, Huang D, Tran JT, Kelner MJ, Reed SL, McLawhon RW, Voss JE, Nemazee D, Fitzgerald RL. Commercial Serology Assays Predict Neutralization Activity against SARS-CoV-2. Clin Chem 2021;67:404-14. [PMID: 33084854 DOI: 10.1093/clinchem/hvaa262] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 19.0] [Reference Citation Analysis]
|
| 241 |
Hsu LY, Lee CC, Green JA, Ang B, Paton NI, Lee L, Villacian JS, Lim PL, Earnest A, Leo YS. Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts. Emerg Infect Dis. 2003;9:713-717. [PMID: 12781012 DOI: 10.3201/eid0906.030264] [Cited by in Crossref: 169] [Cited by in F6Publishing: 163] [Article Influence: 8.9] [Reference Citation Analysis]
|
| 242 |
Ooi GC, Daqing M. SARS: radiological features. Respirology 2003;8 Suppl:S15-9. [PMID: 15018128 DOI: 10.1046/j.1440-1843.2003.00519.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 243 |
Iwasaki M, Saito J, Zhao H, Sakamoto A, Hirota K, Ma D. Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications. Inflammation 2021;44:13-34. [PMID: 33029758 DOI: 10.1007/s10753-020-01337-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 244 |
Lei HY, Ding YH, Nie K, Dong YM, Xu JH, Yang ML, Liu MQ, Wei L, Nasser MI, Xu LY, Zhu P, Zhao MY. Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver. Biomed Pharmacother 2021;133:111064. [PMID: 33378966 DOI: 10.1016/j.biopha.2020.111064] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 245 |
Yuan X, Yao Z, Shan Y, Chen B, Yang Z, Wu J, Zhao Z, Chen J, Cong Y. Nucleolar localization of non-structural protein 3b, a protein specifically encoded by the severe acute respiratory syndrome coronavirus. Virus Res 2005;114:70-9. [PMID: 16046244 DOI: 10.1016/j.virusres.2005.06.001] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 246 |
Leowattana W. Angiotensin-converting enzyme 2 receptors, chronic liver diseases, common medications, and clinical outcomes in coronavirus disease 2019 patients. World J Virol 2021; 10(3): 86-96 [PMID: 34079691 DOI: 10.5501/wjv.v10.i3.86] [Reference Citation Analysis]
|
| 247 |
He Z, Zhao C, Dong Q, Zhuang H, Song S, Peng G, Dwyer DE. Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets. Int J Infect Dis 2005;9:323-30. [PMID: 16095942 DOI: 10.1016/j.ijid.2004.07.014] [Cited by in Crossref: 115] [Cited by in F6Publishing: 106] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 248 |
Parker MJ, Goldman RD. Paediatric emergency department staff perceptions of infection control measures against severe acute respiratory syndrome. Emerg Med J 2006;23:349-53. [PMID: 16627834 DOI: 10.1136/emj.2005.026146] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 249 |
Vardhana SA, Wolchok JD. The many faces of the anti-COVID immune response. J Exp Med 2020;217:e20200678. [PMID: 32353870 DOI: 10.1084/jem.20200678] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 250 |
Yip PSF, Lam KF, Lau EHY, Chau PH, Tsang KW, Chao A. A comparison study of realtime fatality rates: severe acute respiratory syndrome in Hong Kong, Singapore, Taiwan, Toronto and Beijing, China. J R Stat Soc Ser A Stat Soc 2005;168:233-43. [PMID: 32367908 DOI: 10.1111/j.1467-985X.2004.00345.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 251 |
Kleen TO, Galdon AA, MacDonald AS, Dalgleish AG. Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and "New Old Friends". Front Immunol 2020;11:2059. [PMID: 33013871 DOI: 10.3389/fimmu.2020.02059] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 252 |
Samrat SK, Tharappel AM, Li Z, Li H. Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development. Virus Res 2020;288:198141. [PMID: 32846196 DOI: 10.1016/j.virusres.2020.198141] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 18.0] [Reference Citation Analysis]
|
| 253 |
Isakbaeva ET, Khetsuriani N, Beard RS, Peck A, Erdman D, Monroe SS, Tong S, Ksiazek TG, Lowther S, Pandya-Smith I, Anderson LJ, Lingappa J, Widdowson MA; SARS Investigation Group. SARS-associated coronavirus transmission, United States. Emerg Infect Dis 2004;10:225-31. [PMID: 15030687 DOI: 10.3201/eid1002.030734] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 254 |
Christian MD, Loutfy M, McDonald LC, Martinez KF, Ofner M, Wong T, Wallington T, Gold WL, Mederski B, Green K, Low DE; SARS Investigation Team. Possible SARS coronavirus transmission during cardiopulmonary resuscitation. Emerg Infect Dis 2004;10:287-93. [PMID: 15030699 DOI: 10.3201/eid1002.030700] [Cited by in Crossref: 170] [Cited by in F6Publishing: 138] [Article Influence: 9.4] [Reference Citation Analysis]
|
| 255 |
Rajakaruna SJ, Liu WB, Ding YB, Cao GW. Strategy and technology to prevent hospital-acquired infections: Lessons from SARS, Ebola, and MERS in Asia and West Africa. Mil Med Res 2017;4:32. [PMID: 29502517 DOI: 10.1186/s40779-017-0142-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 256 |
Sakai Y, Kawachi K, Terada Y, Omori H, Matsuura Y, Kamitani W. Two-amino acids change in the nsp4 of SARS coronavirus abolishes viral replication. Virology 2017;510:165-74. [PMID: 28738245 DOI: 10.1016/j.virol.2017.07.019] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 257 |
Berry M, Gamieldien J, Fielding BC. Identification of new respiratory viruses in the new millennium. Viruses 2015;7:996-1019. [PMID: 25757061 DOI: 10.3390/v7030996] [Cited by in Crossref: 85] [Cited by in F6Publishing: 71] [Article Influence: 12.1] [Reference Citation Analysis]
|
| 258 |
André M, Talarmin F, Le Guen P, Nicolas X, Garcia JF, Natali F. [Asymptomatic forms of the Severe Acute Respiratory Syndrome (SARS)]. Rev Mal Respir 2005;22:135-41. [PMID: 15968766 DOI: 10.1016/s0761-8425(05)85444-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 259 |
Khan MMA, Khan MN, Mustagir MG, Rana J, Islam MS, Kabir MI. Effects of underlying morbidities on the occurrence of deaths in COVID-19 patients: A systematic review and meta-analysis. J Glob Health 2020;10:020503. [PMID: 33110586 DOI: 10.7189/jogh.10.020503] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 260 |
Shiu SY, Reiter RJ, Tan DX, Pang SF. Urgent search for safe and effective treatments of severe acute respiratory syndrome: is melatonin a promising candidate drug? J Pineal Res 2003;35:69-70. [PMID: 12823616 DOI: 10.1034/j.1600-079x.2003.00068.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 261 |
Dutronc H, Dupon M, Cipriano G, Lafarie S, Lafon ME, Fleury HJ, Bocquentin F, Neau D, Ragnaud JM. [Severe acute respiratory syndrome: one case of indirect transmission by Coronavirus]. Rev Med Interne 2004;25:607-9. [PMID: 15276297 DOI: 10.1016/j.revmed.2004.05.001] [Reference Citation Analysis]
|
| 262 |
Araya S, Tsegay YG, Atlaw A, Aragaw M, Tadlo G, Tsegaye N, Kahase D, Gebreyohanes Z, Bitew M, Berhane N. Organ function biomarker abnormalities, associated factors and disease outcome among hospitalized patients with COVID-19. Biomark Med 2022. [PMID: 35234521 DOI: 10.2217/bmm-2021-0681] [Reference Citation Analysis]
|
| 263 |
Saijo M, Morikawa S, Fukushi S, Mizutani T, Hasegawa H, Nagata N, Iwata N, Kurane I. Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus. Antiviral Res. 2005;66:159-163. [PMID: 15911031 DOI: 10.1016/j.antiviral.2005.01.003] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 264 |
Lin M, Tseng HK, Trejaut JA, Lee HL, Loo JH, Chu CC, Chen PJ, Su YW, Lim KH, Tsai ZU, Lin RY, Lin RS, Huang CH. Association of HLA class I with severe acute respiratory syndrome coronavirus infection. BMC Med Genet. 2003;4:9. [PMID: 12969506 DOI: 10.1186/1471-2350-4-9] [Cited by in Crossref: 164] [Cited by in F6Publishing: 162] [Article Influence: 8.6] [Reference Citation Analysis]
|
| 265 |
Nicasio M, Sautto G, Clementi N, Diotti RA, Criscuolo E, Castelli M, Solforosi L, Clementi M, Burioni R. Neutralization interfering antibodies: a "novel" example of humoral immune dysfunction facilitating viral escape? Viruses 2012;4:1731-52. [PMID: 23170181 DOI: 10.3390/v4091731] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 266 |
Timothy HR, Peter AC, Devilliers S, Kin LO, Alex NW. Evaluation of WHO criteria for idenfifying patients with severe acute respiratory syndrome out of hospital: prospective observational study. BMF. 2003;326:1354-1358. [PMID: 12816820 DOI: 10.1136/bmj.326.7403.1354] [Cited by in Crossref: 75] [Cited by in F6Publishing: 72] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 267 |
Cinatl J Jr, Michaelis M, Scholz M, Doerr HW. Role of interferons in the treatment of severe acute respiratory syndrome. Expert Opin Biol Ther. 2004;4:827-836. [PMID: 15174965 DOI: 10.1517/14712598.4.6.827] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 268 |
So RC, Ko J, Yuan YW, Lam JJ, Louie L. Severe Acute Respiratory Syndrome and sport: facts and fallacies. Sports Med 2004;34:1023-33. [PMID: 15575793 DOI: 10.2165/00007256-200434150-00002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 269 |
Donnelly CA, Ghani AC, Leung GM, Hedley AJ, Fraser C, Riley S, Abu-Raddad LJ, Ho LM, Thach TQ, Chau P. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet. 2003;361:1761-1766. [PMID: 12781533 DOI: 10.1016/s0140-6736(03)13410-1] [Cited by in Crossref: 573] [Cited by in F6Publishing: 401] [Article Influence: 30.2] [Reference Citation Analysis]
|
| 270 |
Guery B, d'Escrivan T, Georges H, Legout L, Leroy O, Viget N, Faure K. [Viral pneumonia in immunocompetent patients]. Reanimation 2004;13:226-37. [PMID: 32288722 DOI: 10.1016/j.reaurg.2004.02.009] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 271 |
Lam WK, Zhong NS, Tan WC. Overview on SARS in Asia and the world. Respirology. 2003;8 Suppl:S2-S5. [PMID: 15018125 DOI: 10.1046/j.1440-1843.2003.00516.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 272 |
So LK, Lau AC, Yam LY, Cheung TM, Poon E, Yung RW, Yuen KY. Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet. 2003;361:1615-1617. [PMID: 12747883 DOI: 10.1016/s0140-6736(03)13265-5] [Cited by in Crossref: 205] [Cited by in F6Publishing: 140] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 273 |
Adachi D, Johnson G, Draker R, Ayers M, Mazzulli T, Talbot PJ, Tellier R. Comprehensive detection and identification of human coronaviruses, including the SARS-associated coronavirus, with a single RT-PCR assay. J Virol Methods 2004;122:29-36. [PMID: 15488617 DOI: 10.1016/j.jviromet.2004.07.008] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 274 |
Groneberg DA, Poutanen SM, Low DE, Lode H, Welte T, Zabel P. Treatment and vaccines for severe acute respiratory syndrome. Lancet Infect Dis 2005;5:147-55. [PMID: 15766649 DOI: 10.1016/S1473-3099(05)01307-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 38] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 275 |
Kim SB, Huh K, Heo JY, Joo EJ, Kim YJ, Choi WS, Kim YJ, Seo YB, Yoon YK, Ku NS, Jeong SJ, Kim SH, Peck KR, Yeom JS. Interim Guidelines on Antiviral Therapy for COVID-19. Infect Chemother 2020;52:281-304. [PMID: 32342676 DOI: 10.3947/ic.2020.52.2.281] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 276 |
Wang Y, Liu S, Liu H, Li W, Lin F, Jiang L, Li X, Xu P, Zhang L, Zhao L, Cao Y, Kang J, Yang J, Li L, Liu X, Li Y, Nie R, Mu J, Lu F, Zhao S, Lu J, Zhao J. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19. J Hepatol. 2020;73:807-816. [PMID: 32437830 DOI: 10.1016/j.jhep.2020.05.002] [Cited by in Crossref: 158] [Cited by in F6Publishing: 161] [Article Influence: 79.0] [Reference Citation Analysis]
|
| 277 |
Lang ZW, Zhang LJ, Zhang SJ, Meng X, Li JQ, Song CZ, Sun L, Zhou YS, Dwyer DE. A clinicopathological study of three cases of severe acute respiratory syndrome (SARS). Pathology 2003;35:526-31. [PMID: 14660106 DOI: 10.1080/00313020310001619118] [Cited by in Crossref: 66] [Cited by in F6Publishing: 70] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 278 |
Ding Y, Wang H, Shen H, Li Z, Geng J, Han H, Cai J, Li X, Kang W, Weng D, Lu Y, Wu D, He L, Yao K. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China. J Pathol 2003;200:282-9. [PMID: 12845623 DOI: 10.1002/path.1440] [Cited by in Crossref: 446] [Cited by in F6Publishing: 430] [Article Influence: 23.5] [Reference Citation Analysis]
|
| 279 |
Tsang KW, File TM Jr. Respiratory infections unique to Asia. Respirology 2008;13:937-49. [PMID: 18945321 DOI: 10.1111/j.1440-1843.2008.01409.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 280 |
Chow KY, Lee CE, Ling ML, Heng DM, Yap SG. Outbreak of severe acute respiratory syndrome in a tertiary hospital in Singapore, linked to an index patient with atypical presentation: epidemiological study. BMJ 2004;328:195. [PMID: 14726369 DOI: 10.1136/bmj.37939.465729.44] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 281 |
Bradford IM. Tales from the frontline: the colorectal battle against SARS. Colorectal Dis. 2004;6:121-123. [PMID: 15008911 DOI: 10.1111/j.1462-8910.2004.00600.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 282 |
Breiman RF, Evans MR, Preiser W, Maguire J, Schnur A, Li A, Bekedam H, MacKenzie JS. Role of China in the quest to define and control severe acute respiratory syndrome. Emerg Infect Dis 2003;9:1037-41. [PMID: 14519236 DOI: 10.3201/eid0909.030390] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 283 |
Yamate M, Yamashita M, Goto T, Tsuji S, Li YG, Warachit J, Yunoki M, Ikuta K. Establishment of Vero E6 cell clones persistently infected with severe acute respiratory syndrome coronavirus. Microbes Infect 2005;7:1530-40. [PMID: 16269264 DOI: 10.1016/j.micinf.2005.05.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 284 |
Yam WC, Chan KH, Poon LL, Guan Y, Yuen KY, Seto WH, Peiris JS. Evaluation of reverse transcription-PCR assays for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus. J Clin Microbiol 2003;41:4521-4. [PMID: 14532176 DOI: 10.1128/JCM.41.10.4521-4524.2003] [Cited by in Crossref: 118] [Cited by in F6Publishing: 95] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 285 |
Ali N. Relationship Between COVID-19 Infection and Liver Injury: A Review of Recent Data. Front Med (Lausanne) 2020;7:458. [PMID: 32793619 DOI: 10.3389/fmed.2020.00458] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 286 |
Lim EC, Seet RC, Lee KH, Wilder-Smith EP, Chuah BY, Ong BK. Headaches and the N95 face-mask amongst healthcare providers. Acta Neurol Scand 2006;113:199-202. [PMID: 16441251 DOI: 10.1111/j.1600-0404.2005.00560.x] [Cited by in Crossref: 142] [Cited by in F6Publishing: 114] [Article Influence: 8.9] [Reference Citation Analysis]
|
| 287 |
Muller MP, McGeer A, Straus SE, Hawryluck L, Gold WL. Clinical trials and novel pathogens: lessons learned from SARS. Emerg Infect Dis 2004;10:389-94. [PMID: 15109402 DOI: 10.3201/eid1003.030702] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
|
| 288 |
Kwan BC, Leung CB, Szeto CC, Wang AY, Li PK. Severe acute respiratory syndrome in a hemodialysis patient. Am J Kidney Dis 2003;42:1069-74. [PMID: 14582051 DOI: 10.1016/j.ajkd.2003.07.022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 289 |
Singh K, Eong OE, Kumarsil B, Saw S, Sethi S. Severe acute respiratory syndrome without respiratory symptoms or abnormal chest radiograph findings. Clin Infect Dis 2004;38:585-6. [PMID: 14765354 DOI: 10.1086/381437] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 290 |
Hachim IY, Hachim MY, Naeem KB, Hannawi H, Al Salmi I, Al-Zakwani I, Hannawi S. Kidney Dysfunction among COVID-19 Patients in the United Arab Emirates. Oman Med J 2021;36:e221. [PMID: 33585042 DOI: 10.5001/omj.2020.92] [Reference Citation Analysis]
|
| 291 |
Cao G, Li P, Chen Y, Fang K, Chen B, Wang S, Feng X, Wang Z, Xiong M, Zheng R, Guo M, Sun Q. A Risk Prediction Model for Evaluating the Disease Progression of COVID-19 Pneumonia. Front Med (Lausanne) 2020;7:556886. [PMID: 33251226 DOI: 10.3389/fmed.2020.556886] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 292 |
Berger A, Drosten Ch, Doerr HW, Stürmer M, Preiser W. Severe acute respiratory syndrome (SARS)--paradigm of an emerging viral infection. J Clin Virol 2004;29:13-22. [PMID: 14675864 DOI: 10.1016/j.jcv.2003.09.011] [Cited by in Crossref: 81] [Cited by in F6Publishing: 57] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 293 |
Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, Huan Y, Yang P, Zhang Y, Deng W, Bao L, Zhang B, Liu G, Wang Z, Chappell M, Liu Y, Zheng D, Leibbrandt A, Wada T, Slutsky AS, Liu D, Qin C, Jiang C, Penninger JM. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11:875-879. [PMID: 16007097 DOI: 10.1038/nm1267] [Cited by in Crossref: 1930] [Cited by in F6Publishing: 1757] [Article Influence: 113.5] [Reference Citation Analysis]
|
| 294 |
Cheng VC, Chan JF, To KK, Yuen KY. Clinical management and infection control of SARS: lessons learned. Antiviral Res 2013;100:407-19. [PMID: 23994190 DOI: 10.1016/j.antiviral.2013.08.016] [Cited by in Crossref: 90] [Cited by in F6Publishing: 84] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 295 |
Wu CY, King KY, Kuo CJ, Fang JM, Wu YT, Ho MY, Liao CL, Shie JJ, Liang PH, Wong CH. Stable benzotriazole esters as mechanism-based inactivators of the severe acute respiratory syndrome 3CL protease. Chem Biol 2006;13:261-8. [PMID: 16638531 DOI: 10.1016/j.chembiol.2005.12.008] [Cited by in Crossref: 86] [Cited by in F6Publishing: 77] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 296 |
Lai CC, Jou MJ, Huang SY, Li SW, Wan L, Tsai FJ, Lin CW. Proteomic analysis of up-regulated proteins in human promonocyte cells expressing severe acute respiratory syndrome coronavirus 3C-like protease. Proteomics. 2007;7:1446-1460. [PMID: 17407183 DOI: 10.1002/pmic.200600459] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 297 |
Hoang T, Anh TTT. Treatment Options for Severe Acute Respiratory Syndrome, Middle East Respiratory Syndrome, and Coronavirus Disease 2019: a Review of Clinical Evidence. Infect Chemother 2020;52:317-34. [PMID: 32869558 DOI: 10.3947/ic.2020.52.3.317] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 298 |
Chim SS, Chiu RW, Lo YM. Genomic sequencing of the severe acute respiratory syndrome-coronavirus. Methods Mol Biol 2006;336:177-94. [PMID: 16916263 DOI: 10.1385/1-59745-074-X:177] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 299 |
Tee AK, Oh HM, Lien CT, Narendran K, Heng BH, Ling AE. Atypical SARS in geriatric patient. Emerg Infect Dis 2004;10:261-4. [PMID: 15030694 DOI: 10.3201/eid1002.030322] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 300 |
Association of periOperative Registered Nurses. AORN guidance statement: human and avian influenza and severe acute respiratory syndrome. AORN J 2006;84:284-98. [PMID: 16927592 DOI: 10.1016/s0001-2092(06)60496-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 301 |
Domínguez A, Gudiol F, Pumarola T, Salleras L. [Severe acute respiratory syndrome epidemics: the end or a hiatus of the epidemic?]. Med Clin (Barc) 2003;121:340-6. [PMID: 14499072 DOI: 10.1016/s0025-7753(03)73942-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 302 |
Krishnamoorthy S, Swain B, Verma RS, Gunthe SS. SARS-CoV, MERS-CoV, and 2019-nCoV viruses: an overview of origin, evolution, and genetic variations. Virusdisease 2020;:1-13. [PMID: 33102628 DOI: 10.1007/s13337-020-00632-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 303 |
Gao F, Ou HY, Chen LL, Zheng WX, Zhang CT. Prediction of proteinase cleavage sites in polyproteins of coronaviruses and its applications in analyzing SARS-CoV genomes. FEBS Lett 2003;553:451-6. [PMID: 14572668 DOI: 10.1016/s0014-5793(03)01091-3] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 304 |
Tong TR. SARS infection control. Lancet 2003;362:76; author reply 76-7. [PMID: 12853206 DOI: 10.1016/S0140-6736(03)13816-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 305 |
Li Z, Wang Y. Air Emergency Transport under COVID-19: Impact, Measures, and Future. Journal of Advanced Transportation 2021;2021:1-14. [DOI: 10.1155/2021/5560994] [Reference Citation Analysis]
|
| 306 |
Hay RJ. A viral rash: the impact of COVID-19 infection on the skin. Br J Dermatol 2020;183:1-2. [PMID: 32613651 DOI: 10.1111/bjd.19188] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 307 |
Kuiken T, Fouchier RA, Schutten M, Rimmelzwaan GF, van Amerongen G, van Riel D, Laman JD, de Jong T, van Doornum G, Lim W. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet. 2003;362:263-270. [PMID: 12892955 DOI: 10.1016/s0140-6736(03)13967-0] [Cited by in Crossref: 693] [Cited by in F6Publishing: 550] [Article Influence: 36.5] [Reference Citation Analysis]
|
| 308 |
Liatsos GD. Controversies’ clarification regarding ribavirin efficacy in measles and coronaviruses: Comprehensive therapeutic approach strictly tailored to COVID-19 disease stages. World J Clin Cases 2021; 9(19): 5135-5178 [PMID: 34307564 DOI: 10.12998/wjcc.v9.i19.5135] [Reference Citation Analysis]
|
| 309 |
Pan X, Ojcius DM, Gao T, Li Z, Pan C, Pan C. Lessons learned from the 2019-nCoV epidemic on prevention of future infectious diseases. Microbes Infect 2020;22:86-91. [PMID: 32088333 DOI: 10.1016/j.micinf.2020.02.004] [Cited by in Crossref: 49] [Cited by in F6Publishing: 37] [Article Influence: 24.5] [Reference Citation Analysis]
|
| 310 |
Market M, Angka L, Martel AB, Bastin D, Olanubi O, Tennakoon G, Boucher DM, Ng J, Ardolino M, Auer RC. Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies. Front Immunol 2020;11:1512. [PMID: 32655581 DOI: 10.3389/fimmu.2020.01512] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 28.5] [Reference Citation Analysis]
|
| 311 |
Ben-Nun M, Riley P, Turtle J, Bacon DP, Riley S. Forecasting national and regional influenza-like illness for the USA. PLoS Comput Biol 2019;15:e1007013. [PMID: 31120881 DOI: 10.1371/journal.pcbi.1007013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 312 |
Yang YH, Huang YH, Chuang YH, Peng CM, Wang LC, Lin YT, Chiang BL. Autoantibodies against human epithelial cells and endothelial cells after severe acute respiratory syndrome (SARS)-associated coronavirus infection. J Med Virol 2005;77:1-7. [PMID: 16032747 DOI: 10.1002/jmv.20407] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 313 |
Ohara H. Contribution of technical guidance on nosocomial infection control to the containment of Severe Acute Respiratory Syndrome in Vietnam. Int Congr Ser 2004;1267:79-87. [PMID: 32288147 DOI: 10.1016/j.ics.2004.01.086] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 314 |
Chen SY, Su CP, Ma MH, Chiang WC, Hsu CY, Ko PC, Tsai KC, Yen ZS, Shih FY, Chen SC, Chen WJ. Predictive model of diagnosing probable cases of severe acute respiratory syndrome in febrile patients with exposure risk. Ann Emerg Med 2004;43:1-5. [PMID: 14707932 DOI: 10.1016/s0196-0644(03)00817-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 315 |
Salleras L. [Severe Acute Respiratory Syndrome. A new emergent infectious disease]. Med Clin (Barc) 2003;120:619-21. [PMID: 12732127 DOI: 10.1016/s0025-7753(03)73789-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 316 |
Hsu CH, Hwang KC, Chao CL, Chang SG, Ho MS, Lin JG, Chang HH, Kao ST, Chen YM, Chou P. An Evaluation of the Additive Effect of Natural Herbal Medicine on SARS or SARS-like Infectious Diseases in 2003: A Randomized, Double-blind, and Controlled Pilot Study. Evid Based Complement Alternat Med 2008;5:355-62. [PMID: 18830453 DOI: 10.1093/ecam/nem035] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 317 |
Ning T, Liu S, Xu J, Yang Y, Zhang N, Xie S, Min L, Zhang S, Zhu S, Wang Y. Potential intestinal infection and faecal-oral transmission of human coronaviruses. Rev Med Virol 2022;:e2363. [PMID: 35584273 DOI: 10.1002/rmv.2363] [Reference Citation Analysis]
|
| 318 |
Nishiura H, Patanarapelert K, Sriprom M, Sarakorn W, Sriyab S, Ming Tang I. Modelling potential responses to severe acute respiratory syndrome in Japan: the role of initial attack size, precaution, and quarantine. J Epidemiol Community Health 2004;58:186-91. [PMID: 14966229 DOI: 10.1136/jech.2003.014894] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 319 |
Pormohammad A, Ghorbani S, Baradaran B, Khatami A, J Turner R, Mansournia MA, Kyriacou DN, Idrovo JP, Bahr NC. Clinical characteristics, laboratory findings, radiographic signs and outcomes of 61,742 patients with confirmed COVID-19 infection: A systematic review and meta-analysis. Microb Pathog 2020;147:104390. [PMID: 32681968 DOI: 10.1016/j.micpath.2020.104390] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 13.5] [Reference Citation Analysis]
|
| 320 |
Wong CK, Lam CW, Wu AK, Ip WK, Lee NL, Chan IH, Lit LC, Hui DS, Chan MH, Chung SS, Sung JJ. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol. 2004;136:95-103. [PMID: 15030519 DOI: 10.1111/j.1365-2249.2004.02415.x] [Cited by in Crossref: 742] [Cited by in F6Publishing: 701] [Article Influence: 41.2] [Reference Citation Analysis]
|
| 321 |
Knowles SR, Phillips EJ, Dresser L, Matukas L. Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada. Clin Infect Dis. 2003;37:1139-1142. [PMID: 14523782 DOI: 10.1086/378304] [Cited by in Crossref: 80] [Cited by in F6Publishing: 71] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 322 |
Lin CW, Tsai FJ, Tsai CH, Lai CC, Wan L, Ho TY, Hsieh CC, Chao PD. Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antiviral Res 2005;68:36-42. [PMID: 16115693 DOI: 10.1016/j.antiviral.2005.07.002] [Cited by in Crossref: 223] [Cited by in F6Publishing: 197] [Article Influence: 13.9] [Reference Citation Analysis]
|
| 323 |
Bi P, Wang J, Hiller JE. Weather: driving force behind the transmission of severe acute respiratory syndrome in China? Intern Med J 2007;37:550-4. [PMID: 17445010 DOI: 10.1111/j.1445-5994.2007.01358.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 324 |
Hsueh PR, Hsiao CH, Yeh SH, Wang WK, Chen PJ, Wang JT, Chang SC, Kao CL, Yang PC; SARS Research Group of National Taiwan University College of Medicine and National Taiwan University Hospital. Microbiologic characteristics, serologic responses, and clinical manifestations in severe acute respiratory syndrome, Taiwan. Emerg Infect Dis 2003;9:1163-7. [PMID: 14519257 DOI: 10.3201/eid0909.030367] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 325 |
Groneberg DA, Zhang L, Welte T, Zabel P, Chung KF. Severe acute respiratory syndrome: global initiatives for disease diagnosis. QJM 2003;96:845-52. [PMID: 14566040 DOI: 10.1093/qjmed/hcg146] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 326 |
Jones DL, Baluja MQ, Graham DW, Corbishley A, McDonald JE, Malham SK, Hillary LS, Connor TR, Gaze WH, Moura IB, Wilcox MH, Farkas K. Shedding of SARS-CoV-2 in feces and urine and its potential role in person-to-person transmission and the environment-based spread of COVID-19. Sci Total Environ 2020;749:141364. [PMID: 32836117 DOI: 10.1016/j.scitotenv.2020.141364] [Cited by in Crossref: 72] [Cited by in F6Publishing: 53] [Article Influence: 36.0] [Reference Citation Analysis]
|
| 327 |
Wills BS, Morse JM. Responses of Chinese elderly to the threat of severe acute respiratory syndrome (SARS) in a Canadian community. Public Health Nurs 2008;25:57-68. [PMID: 18173586 DOI: 10.1111/j.1525-1446.2008.00680.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 328 |
Shanmugam C, Mohammed AR, Ravuri S, Luthra V, Rajagopal N, Karre S. COVID-2019 - A comprehensive pathology insight. Pathol Res Pract. 2020;216:153222. [PMID: 32979742 DOI: 10.1016/j.prp.2020.153222] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 329 |
Volkan E. COVID-19: Structural Considerations for Virus Pathogenesis, Therapeutic Strategies and Vaccine Design in the Novel SARS-CoV-2 Variants Era. Mol Biotechnol 2021. [PMID: 34145550 DOI: 10.1007/s12033-021-00353-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 330 |
Tsai MC, Arnold JL, Chuang CC, Chi CH, Liu CC, Yang YJ. Impact of an outbreak of severe acute respiratory syndrome on a hospital in Taiwan, ROC. Emerg Med J 2004;21:311-6. [PMID: 15107369 DOI: 10.1136/emj.2003.011122] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 331 |
Tiwari A, Chan S, Wong A, Tai J, Cheng K, Chan J, Tsang K; Nursing Task Force on Anti-SARS of Queen Mary Hospital. Severe acute respiratory syndrome (SARS) in Hong Kong: patients' experiences. Nurs Outlook 2003;51:212-9. [PMID: 14569227 DOI: 10.1016/j.outlook.2003.07.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 332 |
Momattin H, Mohammed K, Zumla A, Memish ZA, Al-Tawfiq JA. Therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)--possible lessons from a systematic review of SARS-CoV therapy. Int J Infect Dis 2013;17:e792-8. [PMID: 23993766 DOI: 10.1016/j.ijid.2013.07.002] [Cited by in Crossref: 81] [Cited by in F6Publishing: 79] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 333 |
Cibrelus L, Nöel V, Emmanuelli J, Breton G, Longuet P, Rigolli B, Leport C, Vildé JL. [Management of 90 patients presenting with suspected severe acute respiratory syndrome. Experience of a collaboration between epidemiologists and clinicians facing an emerging infectious disease health alert]. Med Mal Infect 2007;37 Suppl 3:S242-50. [PMID: 17997252 DOI: 10.1016/j.medmal.2006.03.006] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 334 |
Zumla A, Chan JF, Azhar EI, Hui DS, Yuen KY. Coronaviruses - drug discovery and therapeutic options. Nat Rev Drug Discov. 2016;15:327-347. [PMID: 26868298 DOI: 10.1038/nrd.2015.37] [Cited by in Crossref: 849] [Cited by in F6Publishing: 775] [Article Influence: 141.5] [Reference Citation Analysis]
|
| 335 |
Singh K, Hsu LY, Villacian JS, Habib A, Fisher D, Tambyah PA. Severe acute respiratory syndrome: lessons from Singapore. Emerg Infect Dis 2003;9:1294-8. [PMID: 14609466 DOI: 10.3201/eid0910.030388] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 336 |
Mozafari Z, Chamjangali MA, Arashi M, Goudarzi N. Suggestion of active 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents using predictive QSAR model based on the combination of ALASSO with an ANN model. SAR QSAR Environ Res 2021;32:863-88. [PMID: 34634208 DOI: 10.1080/1062936X.2021.1975167] [Reference Citation Analysis]
|
| 337 |
Zhong NS, Zheng BJ, Li YM, Poon, Xie ZH, Chan KH, Li PH, Tan SY, Chang Q, Xie JP, Liu XQ, Xu J, Li DX, Yuen KY, Peiris, Guan Y. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003. Lancet. 2003;362:1353-1358. [PMID: 14585636 DOI: 10.1016/s0140-6736(03)14630-2] [Cited by in Crossref: 745] [Cited by in F6Publishing: 493] [Article Influence: 41.4] [Reference Citation Analysis]
|
| 338 |
Yu B, Li X, Chen J, Ouyang M, Zhang H, Zhao X, Tang L, Luo Q, Xu M, Yang L, Huang G, Liu X, Tang J. Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis. J Thromb Thrombolysis 2020;50:548-57. [PMID: 32524516 DOI: 10.1007/s11239-020-02171-y] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 26.0] [Reference Citation Analysis]
|
| 339 |
Nascimento GC, Santos GM, Moura SRB, de Carvalho ARB, da Silva Andrade L, Moura LKB, Mendes F, Moreira MASP, Moura MEB. Bibliometric Analysis Of Research on Coronavirus Infection and Patient Safety in Health Care. TONURSJ 2021;15:373-9. [DOI: 10.2174/1874434602115010373] [Reference Citation Analysis]
|
| 340 |
Chen L, Gui C, Luo X, Yang Q, Günther S, Scandella E, Drosten C, Bai D, He X, Ludewig B, Chen J, Luo H, Yang Y, Yang Y, Zou J, Thiel V, Chen K, Shen J, Shen X, Jiang H. Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro. J Virol 2005;79:7095-103. [PMID: 15890949 DOI: 10.1128/JVI.79.11.7095-7103.2005] [Cited by in Crossref: 116] [Cited by in F6Publishing: 92] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 341 |
Knudsen TB, Kledal TN, Andersen O, Eugen-Olsen J, Kristiansen TB. Severe acute respiratory syndrome--a new coronavirus from the Chinese dragon's lair. Scand J Immunol 2003;58:277-84. [PMID: 12950672 DOI: 10.1046/j.1365-3083.2003.01302.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 342 |
Kao HK, Wang JH, Sung CS, Huang YC, Lien TC. Pneumothorax and mortality in the mechanically ventilated SARS patients: a prospective clinical study. Crit Care 2005;9:R440-5. [PMID: 16137358 DOI: 10.1186/cc3736] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 343 |
Tian D, Sun Y, Zhou J, Ye Q. The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape. Front Immunol 2021;12:751778. [PMID: 34917076 DOI: 10.3389/fimmu.2021.751778] [Reference Citation Analysis]
|
| 344 |
To KK, Hung IF, Chan JF, Yuen KY. From SARS coronavirus to novel animal and human coronaviruses. J Thorac Dis 2013;5 Suppl 2:S103-8. [PMID: 23977429 DOI: 10.3978/j.issn.2072-1439.2013.06.02] [Cited by in F6Publishing: 37] [Reference Citation Analysis]
|
| 345 |
Wang YH, Lin AS, Chao TY, Lu SN, Liu JW, Chen SS, Lin MC. A cluster of patients with severe acute respiratory syndrome in a chest ward in southern Taiwan. Intensive Care Med 2004;30:1228-31. [PMID: 15105985 DOI: 10.1007/s00134-004-2311-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 346 |
Luo C, Luo H, Zheng S, Gui C, Yue L, Yu C, Sun T, He P, Chen J, Shen J, Luo X, Li Y, Liu H, Bai D, Shen J, Yang Y, Li F, Zuo J, Hilgenfeld R, Pei G, Chen K, Shen X, Jiang H. Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A. Biochem Biophys Res Commun 2004;321:557-65. [PMID: 15358143 DOI: 10.1016/j.bbrc.2004.07.003] [Cited by in Crossref: 79] [Cited by in F6Publishing: 76] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 347 |
Lopez V, Chan KS, Wong YC. Nursing care of patients with severe acute respiratory syndrome in the intensive care unit: case reports in Hong Kong. Int J Nurs Stud 2004;41:263-72. [PMID: 14967183 DOI: 10.1016/S0020-7489(03)00137-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 348 |
Goel S, Gupta AK, Singh A, Lenka SR. Preparations and limitations for prevention of severe acute respiratory syndrome in a tertiary care centre of India. J Hosp Infect 2007;66:142-7. [PMID: 17512634 DOI: 10.1016/j.jhin.2007.02.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 349 |
Wong ACP, Lau SKP, Woo PCY. Interspecies Jumping of Bat Coronaviruses. Viruses 2021;13:2188. [PMID: 34834994 DOI: 10.3390/v13112188] [Reference Citation Analysis]
|
| 350 |
Ganesh B, Rajakumar T, Malathi M, Manikandan N, Nagaraj J, Santhakumar A, Elangovan A, Malik YS. Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives. Clin Epidemiol Glob Health 2021;10:100694. [PMID: 33462564 DOI: 10.1016/j.cegh.2020.100694] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 351 |
Cheng VC, Tang BS, Wu AK, Chu CM, Yuen KY. Medical treatment of viral pneumonia including SARS in immunocompetent adult. J Infect. 2004;49:262-273. [PMID: 15474623 DOI: 10.1016/j.jinf.2004.07.010] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 352 |
Cao W, Fang L, Xiao D. What we have learnt from the SARS epdemics in mainland China? Glob Health J 2019;3:55-9. [PMID: 32501415 DOI: 10.1016/j.glohj.2019.09.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 353 |
Mellema RA, Crandell J, Petrey AC. Platelet Dysregulation in the Pathobiology of COVID-19. Hamostaseologie 2021. [PMID: 34879421 DOI: 10.1055/a-1646-3392] [Reference Citation Analysis]
|
| 354 |
Allen U, Hébert D, Churchill C, Read S, Bitnun A, Richardson S, Matlow A, Tellier R, Goldman C, Wray R, King S, Opavsky MA, Ford-Jones E, Hernandez M, Kitai I; SARS Investigative and Management Teams Relevant to Transplantation. The potential impact of SARS on organ transplantation: exercise caution. Pediatr Transplant 2003;7:345-7. [PMID: 14738293 DOI: 10.1034/j.1399-3046.2003.00104.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 355 |
Shaw K. The 2003 SARS outbreak and its impact on infection control practices. Public Health 2006;120:8-14. [PMID: 16297415 DOI: 10.1016/j.puhe.2005.10.002] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 356 |
Venkatasubbaiah M, Dwarakanadha Reddy P, Satyanarayana SV. Literature-based review of the drugs used for the treatment of COVID-19. Curr Med Res Pract 2020;10:100-9. [PMID: 32572376 DOI: 10.1016/j.cmrp.2020.05.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 357 |
Lessler J, Reich NG, Brookmeyer R, Perl TM, Nelson KE, Cummings DA. Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis 2009;9:291-300. [PMID: 19393959 DOI: 10.1016/S1473-3099(09)70069-6] [Cited by in Crossref: 480] [Cited by in F6Publishing: 288] [Article Influence: 36.9] [Reference Citation Analysis]
|
| 358 |
Lara J, Purdy MA, Khudyakov YE. Genetic host specificity of hepatitis E virus. Infect Genet Evol 2014;24:127-39. [PMID: 24667049 DOI: 10.1016/j.meegid.2014.03.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 359 |
Kamming D, Gardam M, Chung F. Anaesthesia and SARS. Br J Anaesth. 2003;90:715-718. [PMID: 12765882 DOI: 10.1093/bja/aeg173] [Cited by in Crossref: 71] [Cited by in F6Publishing: 56] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 360 |
Liu Q, Bai Y, Ge Q, Zhou S, Wen T, Lu Z. Microarray-in-a-tube for detection of multiple viruses. Clin Chem 2007;53:188-94. [PMID: 17158198 DOI: 10.1373/clinchem.2006.071720] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 361 |
Ito N, Mossel EC, Narayanan K, Popov VL, Huang C, Inoue T, Peters CJ, Makino S. Severe acute respiratory syndrome coronavirus 3a protein is a viral structural protein. J Virol 2005;79:3182-6. [PMID: 15709039 DOI: 10.1128/JVI.79.5.3182-3186.2005] [Cited by in Crossref: 93] [Cited by in F6Publishing: 77] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 362 |
Brantl V, Schworm B, Weber G, Schiefelbein J, Kreutzer TC, Michalakis S, Siedlecki J, Priglinger SG. Long-term ocular damage after recovery from COVID-19: lack of evidence at three months. BMC Ophthalmol 2021;21:421. [PMID: 34872499 DOI: 10.1186/s12886-021-02179-9] [Reference Citation Analysis]
|
| 363 |
Tjiu CS, Leung KF, Leong HT. Severe acute respiratory syndrome mimicking acute abdomen. ANZ J Surg 2004;74:179-80. [PMID: 14996177 DOI: 10.1046/j.1445-2197.2004.02977.x] [Reference Citation Analysis]
|
| 364 |
Yeh SH, Wang HY, Tsai CY, Kao CL, Yang JY, Liu HW, Su IJ, Tsai SF, Chen DS, Chen PJ; National Taiwan University SARS Research Team. Characterization of severe acute respiratory syndrome coronavirus genomes in Taiwan: molecular epidemiology and genome evolution. Proc Natl Acad Sci U S A 2004;101:2542-7. [PMID: 14983045 DOI: 10.1073/pnas.0307904100] [Cited by in Crossref: 95] [Cited by in F6Publishing: 79] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 365 |
Chin TW, Chant C, Tanzini R, Wells J. Severe acute respiratory syndrome (SARS): the pharmacist's role. Pharmacotherapy 2004;24:705-12. [PMID: 15222659 DOI: 10.1592/phco.24.8.705.36063] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 366 |
Weiss SR, Leibowitz JL. Coronavirus pathogenesis. Adv Virus Res 2011;81:85-164. [PMID: 22094080 DOI: 10.1016/B978-0-12-385885-6.00009-2] [Cited by in Crossref: 468] [Cited by in F6Publishing: 293] [Article Influence: 46.8] [Reference Citation Analysis]
|
| 367 |
Liu IJ, Hsueh PR, Lin CT, Chiu CY, Kao CL, Liao MY, Wu HC. Disease-specific B Cell epitopes for serum antibodies from patients with severe acute respiratory syndrome (SARS) and serologic detection of SARS antibodies by epitope-based peptide antigens. J Infect Dis 2004;190:797-809. [PMID: 15272409 DOI: 10.1086/422753] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 368 |
Al-Tawfiq JA, Azhar EI, Memish ZA, Zumla A. Middle East Respiratory Syndrome Coronavirus. Semin Respir Crit Care Med 2021;42:828-38. [PMID: 34918324 DOI: 10.1055/s-0041-1733804] [Reference Citation Analysis]
|
| 369 |
Wang XW, Li JS, Guo TK, Zhen B, Kong QX, Yi B, Li Z, Song N, Jin M, Xiao WJ, Zhu XM, Gu CQ, Yin J, Wei W, Yao W, Liu C, Li JF, Ou GR, Wang MN, Fang TY, Wang GJ, Qiu YH, Wu HH, Chao FH, Li JW. Concentration and detection of SARS coronavirus in sewage from Xiao Tang Shan Hospital and the 309th Hospital. J Virol Methods 2005;128:156-61. [PMID: 15964082 DOI: 10.1016/j.jviromet.2005.03.022] [Cited by in Crossref: 84] [Cited by in F6Publishing: 70] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 370 |
Leung C, Kwan Y, Ko P, Chiu SS, Loung P, Fong N, Lee L, Hui Y, Law HKW, Wong WHS, Chan K, Peiris JSM, Lim WWL, Lau Y, Chiu M. Severe Acute Respiratory Syndrome Among Children. PEDIATRICS 2004;113:e535-43. [DOI: 10.1542/peds.113.6.e535] [Cited by in Crossref: 86] [Cited by in F6Publishing: 80] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 371 |
Baas T, Roberts A, Teal TH, Vogel L, Chen J, Tumpey TM, Katze MG, Subbarao K. Genomic analysis reveals age-dependent innate immune responses to severe acute respiratory syndrome coronavirus. J Virol 2008;82:9465-76. [PMID: 18632870 DOI: 10.1128/JVI.00489-08] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 372 |
Fallahi HR, Keyhan SO, Zandian D, Kim SG, Cheshmi B. Being a front-line dentist during the Covid-19 pandemic: a literature review. Maxillofac Plast Reconstr Surg 2020;42:12. [PMID: 32341913 DOI: 10.1186/s40902-020-00256-5] [Cited by in Crossref: 55] [Cited by in F6Publishing: 37] [Article Influence: 27.5] [Reference Citation Analysis]
|
| 373 |
Stark CJ, Atreya CD. Molecular advances in the cell biology of SARS-CoV and current disease prevention strategies. Virol J 2005;2:35. [PMID: 15833113 DOI: 10.1186/1743-422X-2-35] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 374 |
Mclean RK, Graham SP. The pig as an amplifying host for new and emerging zoonotic viruses. One Health 2022. [DOI: 10.1016/j.onehlt.2022.100384] [Reference Citation Analysis]
|
| 375 |
Chu KH, Tsang WK, Tang CS, Lam MF, Lai FM, To KF, Fung KS, Tang HL, Yan WW, Chan HW, Lai TS, Tong KL, Lai KN. Acute renal impairment in coronavirus-associated severe acute respiratory syndrome. Kidney Int. 2005;67:698-705. [PMID: 15673319 DOI: 10.1111/j.1523-1755.2005.67130.x] [Cited by in Crossref: 245] [Cited by in F6Publishing: 229] [Article Influence: 14.4] [Reference Citation Analysis]
|
| 376 |
Cavanagh D. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus. Avian Pathol. 2003;32:567-582. [PMID: 14676007 DOI: 10.1080/03079450310001621198] [Cited by in Crossref: 208] [Cited by in F6Publishing: 186] [Article Influence: 11.6] [Reference Citation Analysis]
|
| 377 |
Liu T, Gong D, Xiao J, Hu J, He G, Rong Z, Ma W. Cluster infections play important roles in the rapid evolution of COVID-19 transmission: A systematic review. Int J Infect Dis. 2020;99:374-380. [PMID: 32768702 DOI: 10.1016/j.ijid.2020.07.073] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 11.5] [Reference Citation Analysis]
|
| 378 |
Lai ST. Treatment of severe acute respiratory syndrome. Eur J Clin Microbiol Infect Dis. 2005;24:583-591. [PMID: 16172857 DOI: 10.1007/s10096-005-0004-z] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 379 |
Farquharson C, Baguley K. Responding to the severe acute respiratory syndrome (SARS) outbreak: lessons learned in a Toronto emergency department. J Emerg Nurs 2003;29:222-8. [PMID: 12776077 DOI: 10.1067/men.2003.109] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 380 |
Lu R, Yu X, Wang W, Duan X, Zhang L, Zhou W, Xu J, Xu L, Hu Q, Lu J, Ruan L, Wang Z, Tan W. Characterization of human coronavirus etiology in Chinese adults with acute upper respiratory tract infection by real-time RT-PCR assays. PLoS One 2012;7:e38638. [PMID: 22719912 DOI: 10.1371/journal.pone.0038638] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 381 |
Chan WS, Wu C, Chow SC, Cheung T, To KF, Leung WK, Chan PK, Lee KC, Ng HK, Au DM, Lo AW. Coronaviral hypothetical and structural proteins were found in the intestinal surface enterocytes and pneumocytes of severe acute respiratory syndrome (SARS). Mod Pathol 2005;18:1432-9. [PMID: 15920543 DOI: 10.1038/modpathol.3800439] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 382 |
Wang CH, Liu CY, Wan YL, Chou CL, Huang KH, Lin HC, Lin SM, Lin TY, Chung KF, Kuo HP. Persistence of lung inflammation and lung cytokines with high-resolution CT abnormalities during recovery from SARS. Respir Res 2005;6:42. [PMID: 15888207 DOI: 10.1186/1465-9921-6-42] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 383 |
Ye Z, Wong CK, Li P, Xie Y. A SARS-CoV protein, ORF-6, induces caspase-3 mediated, ER stress and JNK-dependent apoptosis. Biochim Biophys Acta 2008;1780:1383-7. [PMID: 18708124 DOI: 10.1016/j.bbagen.2008.07.009] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 384 |
Jang TN, Yeh DY, Shen SH, Huang CH, Jiang JS, Kao SJ. Severe acute respiratory syndrome in Taiwan: analysis of epidemiological characteristics in 29 cases. J Infect 2004;48:23-31. [PMID: 14667789 DOI: 10.1016/j.jinf.2003.09.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 385 |
Hong TC, Mai QL, Cuong DV, Parida M, Minekawa H, Notomi T, Hasebe F, Morita K. Development and evaluation of a novel loop-mediated isothermal amplification method for rapid detection of severe acute respiratory syndrome coronavirus. J Clin Microbiol 2004;42:1956-61. [PMID: 15131154 DOI: 10.1128/JCM.42.5.1956-1961.2004] [Cited by in Crossref: 265] [Cited by in F6Publishing: 156] [Article Influence: 14.7] [Reference Citation Analysis]
|
| 386 |
Wang TL, Jang TN, Huang CH, Kao SJ, Lin CM, Lee FN, Liu CY, Chong CF, Lin CM, Dorji H, Teng HJ, Chang H. Establishing a clinical decision rule of severe acute respiratory syndrome at the emergency department. Ann Emerg Med 2004;43:17-22. [PMID: 14707935 DOI: 10.1016/j.annemergmed.2003.08.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 387 |
Vanderheiden A, Ralfs P, Chirkova T, Upadhyay AA, Zimmerman MG, Bedoya S, Aoued H, Tharp GM, Pellegrini KL, Manfredi C, Sorscher E, Mainou B, Lobby JL, Kohlmeier JE, Lowen AC, Shi PY, Menachery VD, Anderson LJ, Grakoui A, Bosinger SE, Suthar MS. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures. J Virol 2020;94:e00985-20. [PMID: 32699094 DOI: 10.1128/JVI.00985-20] [Cited by in Crossref: 86] [Cited by in F6Publishing: 64] [Article Influence: 43.0] [Reference Citation Analysis]
|
| 388 |
Beigel J. The emerging utility of neopterin? Clin Immunol 2005;116:1-2. [PMID: 15925825 DOI: 10.1016/j.clim.2005.03.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 389 |
McMillan P, Dexhiemer T, Neubig RR, Uhal BD. COVID-19-A Theory of Autoimmunity Against ACE-2 Explained. Front Immunol 2021;12:582166. [PMID: 33833750 DOI: 10.3389/fimmu.2021.582166] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 390 |
Xing W, Hejblum G, Leung GM, Valleron AJ. Anatomy of the epidemiological literature on the 2003 SARS outbreaks in Hong Kong and Toronto: a time-stratified review. PLoS Med 2010;7:e1000272. [PMID: 20454570 DOI: 10.1371/journal.pmed.1000272] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 391 |
He Y, Zhou Y, Wu H, Kou Z, Liu S, Jiang S. Mapping of antigenic sites on the nucleocapsid protein of the severe acute respiratory syndrome coronavirus. J Clin Microbiol 2004;42:5309-14. [PMID: 15528730 DOI: 10.1128/JCM.42.11.5309-5314.2004] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 392 |
Rodrigues PB, Dos Santos Pereira Gomes AB, Genaro LM, Pascoal LB, de Souza APD, Leal RF, Vinolo MAR. Intestinal Microbiota in the SARS-CoV-2 Infection: What Is Known? Adv Exp Med Biol 2021;1327:93-106. [PMID: 34279831 DOI: 10.1007/978-3-030-71697-4_7] [Reference Citation Analysis]
|
| 393 |
Adhikari NK, Fowler RA, Bhagwanjee S, Rubenfeld GD. Critical care and the global burden of critical illness in adults. Lancet 2010;376:1339-46. [PMID: 20934212 DOI: 10.1016/S0140-6736(10)60446-1] [Cited by in Crossref: 591] [Cited by in F6Publishing: 289] [Article Influence: 49.3] [Reference Citation Analysis]
|
| 394 |
Augustine JJ, Kellermann AL, Koplan JP. America's emergency care system and severe acute respiratory syndrome: are we ready? Ann Emerg Med 2004;43:23-6. [PMID: 14707936 DOI: 10.1016/j.annemergmed.2003.11.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 395 |
Kim JH, Kang M, Park E, Chung DR, Kim J, Hwang ES. A Simple and Multiplex Loop-Mediated Isothermal Amplification (LAMP) Assay for Rapid Detection of SARS-CoV. Biochip J 2019;13:341-51. [PMID: 32226589 DOI: 10.1007/s13206-019-3404-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 396 |
Kamitani W, Narayanan K, Huang C, Lokugamage K, Ikegami T, Ito N, Kubo H, Makino S. Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation. Proc Natl Acad Sci USA. 2006;103:12885-12890. [PMID: 16912115 DOI: 10.1073/pnas.0603144103] [Cited by in Crossref: 259] [Cited by in F6Publishing: 244] [Article Influence: 16.2] [Reference Citation Analysis]
|
| 397 |
Wong WC, Wong SY, Lee A, Goggins WB. How to provide an effective primary health care in fighting against severe acute respiratory syndrome: the experiences of two cities. Am J Infect Control 2007;35:50-5. [PMID: 17276791 DOI: 10.1016/j.ajic.2006.06.009] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 398 |
Abdi A, Jalilian M, Sarbarzeh PA, Vlaisavljevic Z. Diabetes and COVID-19: A systematic review on the current evidences. Diabetes Res Clin Pract. 2020;166:108347. [PMID: 32711003 DOI: 10.1016/j.diabres.2020.108347] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 22.0] [Reference Citation Analysis]
|
| 399 |
Narayanan K, Huang C, Lokugamage K, Kamitani W, Ikegami T, Tseng CT, Makino S. Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells. J Virol. 2008;82:4471-4479. [PMID: 18305050 DOI: 10.1128/jvi.02472-07] [Cited by in Crossref: 248] [Cited by in F6Publishing: 194] [Article Influence: 17.7] [Reference Citation Analysis]
|
| 400 |
Tang HL, Cheuk A, Chu KH, Lee W, Wong SH, Cheng YL, Yu AW, Fung KS, Tsang WK, Chan HW, Tong KL. Severe acute respiratory syndrome in haemodialysis patients: a report of two cases. Nephrol Dial Transplant 2003;18:2178-81. [PMID: 13679500 DOI: 10.1093/ndt/gfg454] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 401 |
Scales DC, Green K, Chan AK, Poutanen SM, Foster D, Nowak K, Raboud JM, Saskin R, Lapinsky SE, Stewart TE. Illness in intensive care staff after brief exposure to severe acute respiratory syndrome. Emerg Infect Dis 2003;9:1205-10. [PMID: 14609453 DOI: 10.3201/eid0910.030525] [Cited by in Crossref: 111] [Cited by in F6Publishing: 97] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 402 |
Tang JW, Chan RCW. Severe acute respiratory syndrome (SARS) in intensive care units (ICUs): limiting the risk to healthcare workers. Curr Anaesth Crit Care 2004;15:143-55. [PMID: 32288321 DOI: 10.1016/j.cacc.2004.05.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 403 |
Srivastava S, Garg I. Post COVID-19 infection: Long-term effects on liver and kidneys. World J Meta-Anal 2021; 9(3): 220-233 [DOI: 10.13105/wjma.v9.i3.220] [Reference Citation Analysis]
|
| 404 |
Chan PK, Ip M, Ng KC, Rickjason CW, Wu A, Lee N, Rainer TH, Joynt GM, Sung JJ, Tam JS. Severe acute respiratory syndrome-associated coronavirus infection. Emerg Infect Dis 2003;9:1453-4. [PMID: 14718090 DOI: 10.3201/eid0911.030421] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 405 |
Wang S, Guo F, Liu K, Wang H, Rao S, Yang P, Jiang C. Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2. Virus Res 2008;136:8-15. [PMID: 18554741 DOI: 10.1016/j.virusres.2008.03.004] [Cited by in F6Publishing: 74] [Reference Citation Analysis]
|
| 406 |
Murdoch DR, Chambers ST. Atypical pneumonia--time to breathe new life into a useful term? Lancet Infect Dis 2009;9:512-9. [PMID: 19628176 DOI: 10.1016/S1473-3099(09)70148-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 407 |
Radigan KA, Wunderink RG. Epidemic viral pneumonia and other emerging pathogens. Clin Chest Med 2011;32:451-67. [PMID: 21867815 DOI: 10.1016/j.ccm.2011.05.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 408 |
Hwa KY, Lin WM, Hou YI, Yeh TM. Peptide mimicrying between SARS coronavirus spike protein and human proteins reacts with SARS patient serum. J Biomed Biotechnol 2008;2008:326464. [PMID: 18320019 DOI: 10.1155/2008/326464] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 409 |
Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J, Liu W, Bi Y, Gao GF. Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses. Trends Microbiol. 2016;24:490-502. [PMID: 27012512 DOI: 10.1016/j.tim.2016.03.003] [Cited by in Crossref: 1273] [Cited by in F6Publishing: 1113] [Article Influence: 212.2] [Reference Citation Analysis]
|
| 410 |
Mandell LA, Bartlett JG, Dowell SF, File TM Jr, Musher DM, Whitney C; Infectious Diseases Society of America. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 2003;37:1405-33. [PMID: 14614663 DOI: 10.1086/380488] [Cited by in Crossref: 740] [Cited by in F6Publishing: 558] [Article Influence: 38.9] [Reference Citation Analysis]
|
| 411 |
Lien TC, Sung CS, Lee CH, Kao HK, Huang YC, Liu CY, Perng RP, Wang JH. Characteristic features and outcomes of severe acute respiratory syndrome found in severe acute respiratory syndrome intensive care unit patients. J Crit Care 2008;23:557-64. [PMID: 19056023 DOI: 10.1016/j.jcrc.2007.05.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 412 |
Donnelly CA, Fisher MC, Fraser C, Ghani AC, Riley S, Ferguson NM, Anderson RM. Epidemiological and genetic analysis of severe acute respiratory syndrome. Lancet Infect Dis 2004;4:672-83. [PMID: 15522679 DOI: 10.1016/S1473-3099(04)01173-9] [Cited by in Crossref: 72] [Cited by in F6Publishing: 44] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 413 |
Barlow A, Landolf KM, Barlow B, Yeung SYA, Heavner JJ, Claassen CW, Heavner MS. Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019. Pharmacotherapy 2020;40:416-37. [PMID: 32259313 DOI: 10.1002/phar.2398] [Cited by in Crossref: 101] [Cited by in F6Publishing: 78] [Article Influence: 50.5] [Reference Citation Analysis]
|
| 414 |
Weiss SR, Leibowitz JL. Coronavirus pathogenesis. Adv Virus Res 2011;81:85-164. [PMID: 22094080 DOI: 10.1016/B978-0-12-385885-6.00009-2] [Cited by in Crossref: 426] [Cited by in F6Publishing: 1] [Article Influence: 38.7] [Reference Citation Analysis]
|
| 415 |
Escalera-Antezana JP, Lizon-Ferrufino NF, Maldonado-Alanoca A, Alarcón-De-la-Vega G, Alvarado-Arnez LE, Balderrama-Saavedra MA, Bonilla-Aldana DK, Rodríguez-Morales AJ; LANCOVID. Clinical features of the first cases and a cluster of Coronavirus Disease 2019 (COVID-19) in Bolivia imported from Italy and Spain. Travel Med Infect Dis 2020;35:101653. [PMID: 32247926 DOI: 10.1016/j.tmaid.2020.101653] [Cited by in Crossref: 48] [Cited by in F6Publishing: 36] [Article Influence: 24.0] [Reference Citation Analysis]
|
| 416 |
Bin Nafisah SA, Mzahim BY, Aleid BS, Sheerah SA, Almatrafi DQ, Ciottone GR, AlAnazi KH, Khan AA. The risk of coronavirus to healthcare providers during aerosol-generating procedures: A systematic review and meta-analysis. Ann Thorac Med 2021;16:165-71. [PMID: 34012483 DOI: 10.4103/atm.ATM_497_20] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 417 |
Wang W, Ruan S. Simulating the SARS outbreak in Beijing with limited data. J Theor Biol 2004;227:369-79. [PMID: 15019504 DOI: 10.1016/j.jtbi.2003.11.014] [Cited by in Crossref: 111] [Cited by in F6Publishing: 64] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 418 |
Muller MP, Tomlinson G, Marrie TJ, Tang P, McGeer A, Low DE, Detsky AS, Gold WL. Can routine laboratory tests discriminate between severe acute respiratory syndrome and other causes of community-acquired pneumonia? Clin Infect Dis 2005;40:1079-86. [PMID: 15791504 DOI: 10.1086/428577] [Cited by in Crossref: 71] [Cited by in F6Publishing: 53] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 419 |
Peiris JS, Guan Y. Confronting SARS: a view from Hong Kong. Philos Trans R Soc Lond B Biol Sci 2004;359:1075-9. [PMID: 15306392 DOI: 10.1098/rstb.2004.1482] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 420 |
To KF, Lo AW. Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2). J Pathol 2004;203:740-3. [PMID: 15221932 DOI: 10.1002/path.1597] [Cited by in Crossref: 143] [Cited by in F6Publishing: 125] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 421 |
Zhang B, Zhang J, Chen H, Chen L, Chen Q, Li M, Chen Z, You J, Yang K, Zhang S. Novel coronavirus disease 2019 (COVID-19): relationship between chest CT scores and laboratory parameters. Eur J Nucl Med Mol Imaging 2020;47:2083-9. [PMID: 32399620 DOI: 10.1007/s00259-020-04854-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 422 |
Tsou IY, Loh LE, Kaw GJ, Chan I, Chee TS. Severe acute respiratory syndrome (SARS) in a paediatric cluster in Singapore. Pediatr Radiol 2004;34:43-6. [PMID: 12928757 DOI: 10.1007/s00247-003-1042-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 423 |
Cheng VC, Lau SK, Woo PC, Yuen KY. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev. 2007;20:660-694. [PMID: 17934078 DOI: 10.1128/cmr.00023-07] [Cited by in Crossref: 543] [Cited by in F6Publishing: 342] [Article Influence: 36.2] [Reference Citation Analysis]
|
| 424 |
Haagmans BL, Kuiken T, Martina BE, Fouchier RA, Rimmelzwaan GF, van Amerongen G, van Riel D, de Jong T, Itamura S, Chan KH, Tashiro M, Osterhaus AD. Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat Med. 2004;10:290-293. [PMID: 14981511 DOI: 10.1038/nm1001] [Cited by in Crossref: 285] [Cited by in F6Publishing: 262] [Article Influence: 15.8] [Reference Citation Analysis]
|
| 425 |
Nitsche A, Schweiger B, Ellerbrok H, Niedrig M, Pauli G. SARS coronavirus detection. Emerg Infect Dis 2004;10:1300-3. [PMID: 15324554 DOI: 10.3201/eid1007.030678] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 426 |
Wei WI, Tuen HH, Ng RW, Lam LK. Safe tracheostomy for patients with severe acute respiratory syndrome. Laryngoscope 2003;113:1777-9. [PMID: 14520105 DOI: 10.1097/00005537-200310000-00022] [Cited by in Crossref: 77] [Cited by in F6Publishing: 72] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 427 |
Xu X, Liu Y, Weiss S, Arnold E, Sarafianos SG, Ding J. Molecular model of SARS coronavirus polymerase: implications for biochemical functions and drug design. Nucleic Acids Res 2003;31:7117-30. [PMID: 14654687 DOI: 10.1093/nar/gkg916] [Cited by in Crossref: 115] [Cited by in F6Publishing: 117] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 428 |
Xiong S, Wang YF, Zhang MY, Liu XJ, Zhang CH, Liu SS, Qian CW, Li JX, Lu JH, Wan ZY, Zheng HY, Yan XG, Meng MJ, Fan JL. Immunogenicity of SARS inactivated vaccine in BALB/c mice. Immunol Lett 2004;95:139-43. [PMID: 15388253 DOI: 10.1016/j.imlet.2004.06.014] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 429 |
Chan KY, Ching JC, Xu MS, Cheung AN, Yip SP, Yam LY, Lai ST, Chu CM, Wong AT, Song YQ, Huang FP, Liu W, Chung PH, Leung GM, Chow EY, Chan EY, Chan JC, Ngan HY, Tam P, Chan LC, Sham P, Chan VS, Peiris M, Lin SC, Khoo US. Association of ICAM3 genetic variant with severe acute respiratory syndrome. J Infect Dis 2007;196:271-80. [PMID: 17570115 DOI: 10.1086/518892] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 430 |
Pan HH, Chen CT, Sun HL, Ku MS, Liao PF, Lu KH, Sheu JN, Huang JY, Pai JY, Lue KH. Comparison of the effects of air pollution on outpatient and inpatient visits for asthma: a population-based study in Taiwan. PLoS One 2014;9:e96190. [PMID: 24789041 DOI: 10.1371/journal.pone.0096190] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 431 |
Falzarano D, de Wit E, Martellaro C, Callison J, Munster VJ, Feldmann H. Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin. Sci Rep 2013;3:1686. [PMID: 23594967 DOI: 10.1038/srep01686] [Cited by in Crossref: 199] [Cited by in F6Publishing: 197] [Article Influence: 22.1] [Reference Citation Analysis]
|
| 432 |
Chang PC, Yang CC, Kao KC, Wen MS. Clinical outcomes of patients hospitalized for COVID-19 versus SARS: a meta-analysis. Aging (Albany NY) 2020;12:24552-69. [PMID: 33229624 DOI: 10.18632/aging.104139] [Reference Citation Analysis]
|
| 433 |
Geng H, Liu YM, Chan WS, Lo AW, Au DM, Waye MM, Ho YY. The putative protein 6 of the severe acute respiratory syndrome-associated coronavirus: expression and functional characterization. FEBS Lett 2005;579:6763-8. [PMID: 16310783 DOI: 10.1016/j.febslet.2005.11.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 434 |
Novitzky N, Thomas V. Allogeneic stem cell transplantation with T cell-depleted grafts for lymphoproliferative malignancies. Biol Blood Marrow Transplant 2007;13:107-15. [PMID: 17222759 DOI: 10.1016/j.bbmt.2006.09.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 435 |
Wang H, Rao S, Jiang C. Molecular pathogenesis of severe acute respiratory syndrome. Microbes Infect 2007;9:119-26. [PMID: 17142081 DOI: 10.1016/j.micinf.2006.06.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 436 |
Neogi U, Hill KJ, Ambikan AT, Heng X, Quinn TP, Byrareddy SN, Sönnerborg A, Sarafianos SG, Singh K. Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs. Pathogens 2020;9:E320. [PMID: 32357471 DOI: 10.3390/pathogens9050320] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 437 |
Cinatl J Jr, Michaelis M, Hoever G, Preiser W, Doerr HW. Development of antiviral therapy for severe acute respiratory syndrome. Antiviral Res 2005;66:81-97. [PMID: 15878786 DOI: 10.1016/j.antiviral.2005.03.002] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 438 |
Wang LF, Eaton BT. Bats, civets and the emergence of SARS. Curr Top Microbiol Immunol 2007;315:325-44. [PMID: 17848070 DOI: 10.1007/978-3-540-70962-6_13] [Cited by in Crossref: 65] [Cited by in F6Publishing: 94] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 439 |
Kumaki Y, Wandersee MK, Smith AJ, Zhou Y, Simmons G, Nelson NM, Bailey KW, Vest ZG, Li JK, Chan PK, Smee DF, Barnard DL. Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin. Antiviral Res 2011;90:22-32. [PMID: 21338626 DOI: 10.1016/j.antiviral.2011.02.003] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 440 |
Ho PL, Tang XP, Seto WH. SARS: hospital infection control and admission strategies. Respirology 2003;8 Suppl:S41-5. [PMID: 15018133 DOI: 10.1046/j.1440-1843.2003.00523.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 441 |
Pirola L, Palermo A, Mulinacci G, Ratti L, Fichera M, Invernizzi P, Viganò C, Massironi S. Acute mesenteric ischemia and small bowel imaging findings in COVID-19: A comprehensive review of the literature. World J Gastrointest Surg 2021; 13(7): 702-716 [PMID: 34354803 DOI: 10.4240/wjgs.v13.i7.702] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 442 |
Chim SS, Tong YK, Hung EC, Chiu RW, Lo YM. Genomic sequencing of a SARS coronavirus isolate that predated the Metropole Hotel case cluster in Hong Kong. Clin Chem 2004;50:231-3. [PMID: 14709660 DOI: 10.1373/clinchem.2003.025536] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 443 |
Chong WH, Saha BK, Ananthakrishnan Ramani, Chopra A. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia. Infection 2021;49:591-605. [PMID: 33709380 DOI: 10.1007/s15010-021-01602-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 444 |
Reed KD. Monkeypox, Marshfield Clinic and the Internet: leveraging information technology for public health. Clin Med Res 2004;2:1-3. [PMID: 15931329 DOI: 10.3121/cmr.2.1.1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 445 |
Gumel AB, Ruan S, Day T, Watmough J, Brauer F, van den Driessche P, Gabrielson D, Bowman C, Alexander ME, Ardal S, Wu J, Sahai BM. Modelling strategies for controlling SARS outbreaks. Proc Biol Sci 2004;271:2223-32. [PMID: 15539347 DOI: 10.1098/rspb.2004.2800] [Cited by in Crossref: 197] [Cited by in F6Publishing: 129] [Article Influence: 11.6] [Reference Citation Analysis]
|
| 446 |
Tse GM, To KF, Chan PK, Lo AW, Ng KC, Wu A, Lee N, Wong HC, Mak SM, Chan KF, Hui DS, Sung JJ, Ng HK. Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS). J Clin Pathol 2004;57:260-5. [PMID: 14990596 DOI: 10.1136/jcp.2003.013276] [Cited by in Crossref: 144] [Cited by in F6Publishing: 136] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 447 |
Mukherjee P, Desai P, Ross L, White EL, Avery MA. Structure-based virtual screening against SARS-3CL(pro) to identify novel non-peptidic hits. Bioorg Med Chem 2008;16:4138-49. [PMID: 18343121 DOI: 10.1016/j.bmc.2008.01.011] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 448 |
Falsey AR, Walsh EE. Novel coronavirus and severe acute respiratory syndrome. Lancet 2003;361:1312-3. [PMID: 12711460 DOI: 10.1016/S0140-6736(03)13084-X] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 449 |
Tong TR. Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV). Perspect Med Virol 2006;16:43-95. [PMID: 32287586 DOI: 10.1016/S0168-7069(06)16004-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 450 |
Chan KH, Poon LL, Cheng VC, Guan Y, Hung IF, Kong J, Yam LY, Seto WH, Yuen KY, Peiris JS. Detection of SARS coronavirus in patients with suspected SARS. Emerg Infect Dis. 2004;10:294-299. [PMID: 15030700 DOI: 10.3201/eid1002.030610] [Cited by in Crossref: 193] [Cited by in F6Publishing: 167] [Article Influence: 10.7] [Reference Citation Analysis]
|
| 451 |
Wang LM, Chen YC, Tung SP, Chen CY, Chang SC, Chiang SC, Lee CH. The rationale of fever surveillance to identify patients with severe acute respiratory syndrome in Taiwan. Emerg Med J 2006;23:202-5. [PMID: 16498157 DOI: 10.1136/emj.2005.027037] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 452 |
Darwish HS, Habash MY, Habash WY. Chest computed tomography imaging features in patients with coronavirus disease 2019 (COVID-19). J Int Med Res 2021;49:3000605211010631. [PMID: 33947258 DOI: 10.1177/03000605211010631] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 453 |
Bao M, Zhang Y, Wan M, Dai L, Hu X, Wu X, Wang L, Deng P, Wang J, Chen J, Liu Y, Yu Y, Wang L. Anti-SARS-CoV immunity induced by a novel CpG oligodeoxynucleotide. Clin Immunol 2006;118:180-7. [PMID: 16298165 DOI: 10.1016/j.clim.2005.09.014] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 454 |
Tang JI, Shakespeare TP, Zhang XJ, Lu JJ, Liang S, Wynne CJ, Mukherjee RK, Back MF. Patient satisfaction with doctor-patient interaction in a radiotherapy centre during the severe acute respiratory syndrome outbreak. Australas Radiol 2005;49:304-11. [PMID: 16026437 DOI: 10.1111/j.1440-1673.2005.01467.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 455 |
Martínez-Téllez E, Orús Dotú C, Trujillo-Reyes JC, Guarino M, Cladellas Gutiérrez E, Planas Cánovas G, Ramón Cervelló J, Carvi Mallo A, Venegas Pizarro MDP, León Vintró X, Belda-Sanchis J. Tracheotomy in patients COVID-19: A necessary high risk procedure. Two center experience. Arch Bronconeumol (Engl Ed) 2020;56:673-4. [PMID: 32586706 DOI: 10.1016/j.arbres.2020.05.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 456 |
Horváth E, Rossi L, Mercier C, Lehmann C, Sienkiewicz A, Forró L. Photocatalytic Nanowires-Based Air Filter: Towards Reusable Protective Masks. Adv Funct Mater 2020;30:2004615. [PMID: 32837497 DOI: 10.1002/adfm.202004615] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 17.0] [Reference Citation Analysis]
|
| 457 |
Xu RH, He JF, Evans MR, Peng GW, Field HE, Yu DW, Lee CK, Luo HM, Lin WS, Lin P, Li LH, Liang WJ, Lin JY, Schnur A. Epidemiologic clues to SARS origin in China. Emerg Infect Dis 2004;10:1030-7. [PMID: 15207054 DOI: 10.3201/eid1006.030852] [Cited by in Crossref: 145] [Cited by in F6Publishing: 120] [Article Influence: 8.1] [Reference Citation Analysis]
|
| 458 |
Leong HN, Ang B, Earnest A, Teoh C, Xu W, Leo YS. Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003. Trop Med Int Health. 2004;9:923-927. [PMID: 15303999 DOI: 10.1111/j.1365-3156.2004.01281.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 459 |
Li T, Xie J, He Y, Fan H, Baril L, Qiu Z, Han Y, Xu W, Zhang W, You H, Zuo Y, Fang Q, Yu J, Chen Z, Zhang L. Long-term persistence of robust antibody and cytotoxic T cell responses in recovered patients infected with SARS coronavirus. PLoS One 2006;1:e24. [PMID: 17183651 DOI: 10.1371/journal.pone.0000024] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 460 |
Saijo M, Ogino T, Taguchi F, Fukushi S, Mizutani T, Notomi T, Kanda H, Minekawa H, Matsuyama S, Long HT, Hanh NT, Kurane I, Tashiro M, Morikawa S. Recombinant nucleocapsid protein-based IgG enzyme-linked immunosorbent assay for the serological diagnosis of SARS. J Virol Methods 2005;125:181-6. [PMID: 15794988 DOI: 10.1016/j.jviromet.2005.01.028] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 461 |
Lai KN, Tsang KW, Seto WH, Ooi CG. Clinical, Laboratory, and Radiologic Manifestation of SARS. Curr Infect Dis Rep 2004;6:213-9. [PMID: 15142485 DOI: 10.1007/s11908-004-0011-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 462 |
Weng LM, Su X, Wang XQ. Pain Symptoms in Patients with Coronavirus Disease (COVID-19): A Literature Review. J Pain Res 2021;14:147-59. [PMID: 33531833 DOI: 10.2147/JPR.S269206] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 463 |
Hui DSC, Zumla A. Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features. Infect Dis Clin North Am 2019;33:869-89. [PMID: 31668196 DOI: 10.1016/j.idc.2019.07.001] [Cited by in Crossref: 222] [Cited by in F6Publishing: 187] [Article Influence: 111.0] [Reference Citation Analysis]
|
| 464 |
Liang W, Zhu Z, Guo J, Liu Z, Zhou W, Chin DP, Schuchat A; Beijing Joint SARS Expert Group. Severe acute respiratory syndrome, Beijing, 2003. Emerg Infect Dis 2004;10:25-31. [PMID: 15078593 DOI: 10.3201/eid1001.030553] [Cited by in Crossref: 56] [Cited by in F6Publishing: 40] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 465 |
Van Bever HP, Chng SY, Goh DY. Childhood severe acute respiratory syndrome, coronavirus infections and asthma. Pediatr Allergy Immunol 2004;15:206-9. [PMID: 15209951 DOI: 10.1111/j.1399-3038.2004.00137.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 466 |
Zhang JZ. Severe acute respiratory syndrome and its lesions in digestive system. World J Gastroenterol 2003; 9(6): 1135-1138 [PMID: 12800212 DOI: 10.3748/wjg.v9.i6.1135] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 467 |
Kwan YW, Leung CW, Chiu MC. Diarrhoea as the presenting sign in an adolescent suffering from severe acute respiratory syndrome. Eur J Pediatr 2005;164:227-30. [PMID: 15645282 DOI: 10.1007/s00431-004-1618-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 468 |
Thomas P. SEVERE ACUTE RESPIRATORY SYNDROME. Indian Journal of Medical Microbiology 2003;21:152-60. [DOI: 10.1016/s0255-0857(21)03064-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 469 |
Peng H, Yang LT, Li J, Lu ZQ, Wang LY, Koup RA, Bailer RT, Wu CY. Human memory T cell responses to SARS-CoV E protein. Microbes Infect 2006;8:2424-31. [PMID: 16844400 DOI: 10.1016/j.micinf.2006.05.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 470 |
Yamamoto N, Yang R, Yoshinaka Y, Amari S, Nakano T, Cinatl J, Rabenau H, Doerr HW, Hunsmann G, Otaka A, Tamamura H, Fujii N, Yamamoto N. HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus. Biochem Biophys Res Commun 2004;318:719-25. [PMID: 15144898 DOI: 10.1016/j.bbrc.2004.04.083] [Cited by in Crossref: 194] [Cited by in F6Publishing: 173] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 471 |
Leibowitz JL, Srinivasa R, Williamson ST, Chua MM, Liu M, Wu S, Kang H, Ma XZ, Zhang J, Shalev I, Smith R, Phillips MJ, Levy GA, Weiss SR. Genetic determinants of mouse hepatitis virus strain 1 pneumovirulence. J Virol 2010;84:9278-91. [PMID: 20631137 DOI: 10.1128/JVI.00330-10] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 472 |
Safer M, Letaief H, Hechaichi A, Harizi C, Dhaouadi S, Bouabid L, Darouiche S, Gharbi D, Elmili N, Ben Salah H, Hammami M, Talmoudi K, Moussa R, Charaa N, Termiz H, Ltaief F, Tounekti H, Makhlouf M, Belguith Sriha A, Ben Fredj M, Khalfallah S, Jabrane H, Mchirgui S, Amich C, Dabghi R, Anez Z, Abdelkader L, Mhamdi M, Ouerfeli N, Zoghlami S, Bougatef S, Chahed MK, Bouafif Ben Alaya N. Identification of transmission chains and clusters associated with COVID-19 in Tunisia. BMC Infect Dis 2021;21:453. [PMID: 34011266 DOI: 10.1186/s12879-021-06107-6] [Reference Citation Analysis]
|
| 473 |
McIntosh K. The SARS coronavirus: rapid diagnostics in the limelight. Clin Chem 2003;49:845-6. [PMID: 12765977 DOI: 10.1373/49.6.845] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 474 |
Tsang KW, Mok TY, Wong PC, Ooi GC. Severe acute respiratory syndrome (SARS) in Hong Kong. Respirology 2003;8:259-65. [PMID: 14528875 DOI: 10.1046/j.1440-1843.2003.00486.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 475 |
Correia G, Rodrigues L, Gameiro da Silva M, Gonçalves T. Airborne route and bad use of ventilation systems as non-negligible factors in SARS-CoV-2 transmission. Med Hypotheses 2020;141:109781. [PMID: 32361528 DOI: 10.1016/j.mehy.2020.109781] [Cited by in Crossref: 88] [Cited by in F6Publishing: 61] [Article Influence: 44.0] [Reference Citation Analysis]
|
| 476 |
Rezvani M, Koren G. Pregnancy outcome after exposure to injectable ribavirin during embryogenesis. Reprod Toxicol. 2006;21:113-115. [PMID: 16122903 DOI: 10.1016/j.reprotox.2005.06.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 477 |
Law N, Kumar D. Post-transplant Viral Respiratory Infections in the Older Patient: Epidemiology, Diagnosis, and Management. Drugs Aging 2017;34:743-54. [PMID: 28965331 DOI: 10.1007/s40266-017-0491-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 478 |
Desenclos JC, van der Werf S, Bonmarin I, Levy-Bruhl D, Yazdanpanah Y, Hoen B, Emmanuelli J, Lesens O, Dupon M, Natali F, Michelet C, Reynes J, Guery B, Larsen C, Semaille C, Mouton D, André M, Escriou N, Burguière A, Manuguerra JC, Coignard B, Lepoutre A, Meffre C, Bitar D, Decludt B, Capek I, Antona D, Che D, Herida M, Infuso A, Sauri C, Brücker G, Hubert B, LeGoff D, Scheidegger S. Introduction of SARS in France, March-April, 2003. Emerg Infect Dis 2004;10:195-200. [PMID: 15030682 DOI: 10.3201/eid1002.030351] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 479 |
Christian MD, Poutanen SM, Loutfy MR, Muller MP, Low DE. Severe acute respiratory syndrome. Clin Infect Dis 2004;38:1420-7. [PMID: 15156481 DOI: 10.1086/420743] [Cited by in Crossref: 137] [Cited by in F6Publishing: 113] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 480 |
Cui W, Fan Y, Wu W, Zhang F, Wang JY, Ni AP. Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome. Clin Infect Dis 2003;37:857-9. [PMID: 12955652 DOI: 10.1086/378587] [Cited by in Crossref: 111] [Cited by in F6Publishing: 111] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 481 |
Chen LL, Ou HY, Zhang R, Zhang CT. ZCURVE_CoV: a new system to recognize protein coding genes in coronavirus genomes, and its applications in analyzing SARS-CoV genomes. Biochem Biophys Res Commun 2003;307:382-8. [PMID: 12859968 DOI: 10.1016/s0006-291x(03)01192-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 482 |
Yuan J, Yun H, Lan W, Wang W, Sullivan SG, Jia S, Bittles AH. A climatologic investigation of the SARS-CoV outbreak in Beijing, China. Am J Infect Control 2006;34:234-6. [PMID: 16679182 DOI: 10.1016/j.ajic.2005.12.006] [Cited by in Crossref: 97] [Cited by in F6Publishing: 72] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 483 |
Parashar UD, Anderson LJ. Severe acute respiratory syndrome: review and lessons of the 2003 outbreak. Int J Epidemiol 2004;33:628-34. [PMID: 15155694 DOI: 10.1093/ije/dyh198] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 484 |
Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, Li J, Yao Y, Ge S, Xu G. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97:829-838. [PMID: 32247631 DOI: 10.1016/j.kint.2020.03.005] [Cited by in Crossref: 1036] [Cited by in F6Publishing: 958] [Article Influence: 518.0] [Reference Citation Analysis]
|
| 485 |
Grupo de trabajo de la Asociación Latinoamericana del Tórax (ALAT). [Update to the Latin American Thoracic Association (ALAT) recommendations on community acquired pneumonia]. Arch Bronconeumol 2004;40:364-74. [PMID: 15274866 DOI: 10.1016/s1579-2129(06)60322-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 486 |
Lin CW, Tsai CH, Tsai FJ, Chen PJ, Lai CC, Wan L, Chiu HH, Lin KH. Characterization of trans- and cis-cleavage activity of the SARS coronavirus 3CLpro protease: basis for the in vitro screening of anti-SARS drugs. FEBS Lett 2004;574:131-7. [PMID: 15358553 DOI: 10.1016/j.febslet.2004.08.017] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 487 |
Wong SK, Wai-Chung Lai L, Ho DC, Chau KW, Lo-Kuen Lam C, Hung-Fai Ng C. Sick building syndrome and perceived indoor environmental quality: A survey of apartment buildings in Hong Kong. Habitat Int 2009;33:463-71. [PMID: 32287695 DOI: 10.1016/j.habitatint.2009.03.001] [Cited by in Crossref: 47] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 488 |
McCray PB Jr, Pewe L, Wohlford-Lenane C, Hickey M, Manzel L, Shi L, Netland J, Jia HP, Halabi C, Sigmund CD, Meyerholz DK, Kirby P, Look DC, Perlman S. Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J Virol 2007;81:813-21. [PMID: 17079315 DOI: 10.1128/JVI.02012-06] [Cited by in Crossref: 423] [Cited by in F6Publishing: 310] [Article Influence: 26.4] [Reference Citation Analysis]
|
| 489 |
He Y, Zhou Y, Siddiqui P, Niu J, Jiang S. Identification of immunodominant epitopes on the membrane protein of the severe acute respiratory syndrome-associated coronavirus. J Clin Microbiol 2005;43:3718-26. [PMID: 16081901 DOI: 10.1128/JCM.43.8.3718-3726.2005] [Cited by in Crossref: 57] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 490 |
Columbus C. Mad cow and other maladies: update on emerging infectious diseases. Proc (Bayl Univ Med Cent) 2004;17:411-7. [PMID: 16200129 DOI: 10.1080/08998280.2004.11928005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 491 |
Yang ZY, Kong WP, Huang Y, Roberts A, Murphy BR, Subbarao K, Nabel GJ. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature 2004;428:561-4. [PMID: 15024391 DOI: 10.1038/nature02463] [Cited by in Crossref: 466] [Cited by in F6Publishing: 443] [Article Influence: 25.9] [Reference Citation Analysis]
|
| 492 |
Kumaki Y, Salazar AM, Wandersee MK, Barnard DL. Prophylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol® (Poly IC:LC), in a lethal SARS-CoV-infected BALB/c mouse model. Antiviral Res 2017;139:1-12. [PMID: 27956136 DOI: 10.1016/j.antiviral.2016.12.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 493 |
St-Jean JR, Jacomy H, Desforges M, Vabret A, Freymuth F, Talbot PJ. Human respiratory coronavirus OC43: genetic stability and neuroinvasion. J Virol 2004;78:8824-34. [PMID: 15280490 DOI: 10.1128/JVI.78.16.8824-8834.2004] [Cited by in Crossref: 113] [Cited by in F6Publishing: 89] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 494 |
Xu L, Yang Q, Shi H, Lei S, Liu X, Zhu Y, Wu Q, Ding X, Tian Y, Hu Q, Chen F, Geng Z, Zeng X, Lin L, Cai X, Wu M, Wang Z, Wang Z, Xia G, Wang L. Clinical presentations and outcomes of SARS-CoV-2 infected pneumonia in pregnant women and health status of their neonates. Sci Bull (Beijing) 2020;65:1537-42. [PMID: 32346493 DOI: 10.1016/j.scib.2020.04.040] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 495 |
Mahony JB, Petrich A, Louie L, Song X, Chong S, Smieja M, Chernesky M, Loeb M, Richardson S; Ontario Laboratory Working Group for the Rapid Diagnosis of Emerging Infections. Performance and Cost evaluation of one commercial and six in-house conventional and real-time reverse transcription-pcr assays for detection of severe acute respiratory syndrome coronavirus. J Clin Microbiol 2004;42:1471-6. [PMID: 15070991 DOI: 10.1128/JCM.42.4.1471-1476.2004] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 496 |
Chau TN, Lee PO, Choi KW, Lee CM, Ma KF, Tsang TY, Tso YK, Chiu MC, Tong WL, Yu WC, Lai ST. Value of initial chest radiographs for predicting clinical outcomes in patients with severe acute respiratory syndrome. Am J Med 2004;117:249-54. [PMID: 15308434 DOI: 10.1016/j.amjmed.2004.03.020] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 497 |
Tan EL, Ooi EE, Lin CY, Tan HC, Ling AE, Lim B, Stanton LW. Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs. Emerg Infect Dis. 2004;10:581-586. [PMID: 15200845 DOI: 10.3201/eid1004.030458] [Cited by in Crossref: 154] [Cited by in F6Publishing: 144] [Article Influence: 8.6] [Reference Citation Analysis]
|
| 498 |
Babyn PS, Chu WC, Tsou IY, Wansaicheong GK, Allen U, Bitnun A, Chee TS, Cheng FW, Chiu MC, Fok TF, Hon EK, Gahunia HK, Kaw GJ, Khong PL, Leung CW, Li AM, Manson D, Metreweli C, Ng PC, Read S, Stringer DA. Severe acute respiratory syndrome (SARS): chest radiographic features in children. Pediatr Radiol 2004;34:47-58. [PMID: 14624321 DOI: 10.1007/s00247-003-1081-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
|
